Last10K.com

Aehr Test Systems (AEHR) SEC Filing 10-K Annual report for the fiscal year ending Saturday, May 31, 2014

Aehr Test Systems

CIK: 1040470 Ticker: AEHR

EX-99.1
2
q414-ex99.txt
EXHIBIT 99.1


                                                          Exhibit 99.1

[LOGO]AEHR TEST SYSTEMS

FOR IMMEDIATE RELEASE


Aehr Test Systems                       Investor Relations Contact:
Gary Larson                             Todd Kehrli or Jim Byers
Chief Financial Officer                 MKR Group, Inc.
(510) 623-9400 x321                     (323) 468-2300
                                        aehr@mkr-group.com


Aehr Test Systems Reports Fourth Quarter Fiscal 2014 Financial Results
     Net Sales Up 19% Year-Over-Year; Profitable For Fiscal 2014


Fremont, CA (July 17, 2014) - Aehr Test Systems (Nasdaq: AEHR), a worldwide
supplier of semiconductor test and burn-in equipment, today announced
financial results for the fiscal 2014 fourth quarter and full year ended
May 31, 2014.

Net sales for fiscal year 2014 were $19.7 million, an increase of 19%
compared to net sales of $16.5 million in fiscal 2013. Non-GAAP net income
was $1.3 million, or $0.11 per diluted share, and GAAP net income was
$422,000, or $0.04 per diluted share, for fiscal 2014. This compares to
a non-GAAP net loss of $2.8 million, or a loss of $0.30 per share, and
a GAAP net loss of $3.4 million, or a loss of $0.36 per share, in fiscal
2013. Stock-based compensation expense makes up the difference between
the reported non-GAAP and GAAP amounts.

Net sales in the fourth quarter of fiscal 2014 were $5.4 million, compared
to $5.6 million in the third quarter of fiscal 2014. Aehr Test reported
non-GAAP net income of $443,000, or $0.04 per diluted share, and GAAP
net income of $239,000, or $0.02 per diluted share, in the fourth quarter
of fiscal 2014. This compares to non-GAAP net income of $447,000, or $0.04
per diluted share, and GAAP net income of $212,000, or $0.02 per diluted
share, in the third quarter of fiscal 2014. As of May 31, 2014, the Company's
backlog was $6.0 million, compared with $9.1 million at May 31, 2013.

Gayn Erickson, President and CEO of Aehr Test Systems, commented, "We
are pleased to finish our fiscal year having generated annual net sales
growth of 19 percent and achieving our goal of profitability for the full
year. We had a good fourth quarter, which included solid shipments of
our ABTSTM packaged part burn-in systems and particularly strong shipments
of FOXTM WaferPak contactors.

"We continue to gain momentum in our discussions with several potential
customers for two key products under development: the FOX-1P, our next
generation single wafer test system, and the FOX-XP, our next generation
multiple wafer test and burn-in solution," continued Erickson. "As noted
before, we have taken orders for our new FOX-1P system for both engineering
and production applications and expect first shipments for the FOX-1P
later this calendar year. This system features a massively parallel test
interface, which we believe will provide more test resources than any
other automated test equipment (ATE) system on the market. The hardware
and software for our FOX-1P are directly leveraged into our new FOX-XP
multiple wafer test system.

"As we move into the new fiscal year, we are excited about the three
significant emerging market opportunities we have validated for our next
generation FOX products and our existing ABTS package part test and burn-in
system. These substantial new IC test markets include the SSD Flash testing




Aehr Test Systems Reports Fourth Quarter Fiscal 2014 Financial Results
July 17, 2014
Page 2 of 5

market, the emerging automotive IC testing market, and the wafer level
reliability testing market, all of which we believe will expand our served
available market in calendar year 2015 and beyond from $100 million to
between $400-$500 million. With our new ABTS-P and FOX-P products, we
believe Aehr Test is uniquely positioned to capitalize on these new
emerging markets," Erickson concluded.

Management Conference Call
Aehr Test Systems will host a conference call and webcast today, Thursday,
July 17, 2014 at 5:00 p.m. Eastern (2:00 p.m. PT) to discuss the Company's
fourth quarter fiscal 2014 operating results. To access the call dial
888-427-9419 (+1 719-325-2458 outside the United States) and when prompted
provide the pass code "Aehr Test Systems" to the operator. In addition,
a live and archived webcast of the conference call will be available over
the Internet at www.aehr.com in the Investor Relations section. A replay
of the conference call will also be available via telephone by dialing
888-203-1112 (+1 719-457-0820 outside the United States) and entering
access code 8112057#, beginning 8:00 p.m. ET on July 17, 2014 through
8:00 p.m. ET on July 24, 2014.

About Aehr Test Systems
Headquartered in Fremont, California, Aehr Test Systems is a worldwide
provider of test systems for burning-in and testing logic and memory
integrated circuits and has an installed base of more than 2,500 systems
worldwide. Increased quality and reliability needs of the Automotive and
Mobility integrated circuit markets are driving additional test
requirements, capacity needs and opportunities for Aehr Test products
in package and wafer level test.  Aehr Test has developed and introduced
several innovative products, including the ABTS and FOX families of test
and burn-in systems and the DiePak(R) carrier. The ABTS system is used
in production and qualification testing of packaged parts for both
low-power and high-power logic as well as all common types of memory devices.
The FOX system is a full wafer contact test and burn-in system used for
burn-in and functional test of complex devices, such as leading-edge
memories, digital signal processors, microprocessors, microcontrollers
and systems-on-a-chip. The DiePak carrier is a reusable, temporary package
that enables IC manufacturers to perform cost-effective final test and
burn-in of bare die. For more information, please visit the Company's
website at www.aehr.com.

Safe Harbor Statement
This press release contains certain forward-looking statements based on
current expectations, forecasts and assumptions that involve risks and
uncertainties.  These statements are based on information available to
Aehr Test as of the date hereof and actual results could differ materially
from those stated or implied due to risks and uncertainties. Forward-
looking statements include statements regarding Aehr Test's expectations,
beliefs, intentions or strategies regarding the future including
statements regarding future market opportunities and conditions. The
risks and uncertainties that could cause Aehr Test's results to differ
materially from those expressed or implied by such forward-looking
statements include, without limitation, general market conditions,
customer demand and acceptance of Aehr Test's products and Aehr Test's
ability to execute on its business strategy. See Aehr Test's recent 10-K,
10-Q and other reports from time to time filed with the Securities and
Exchange Commission for a more detailed description of the risks facing
Aehr Test's business. Aehr Test disclaims any obligation to update
information contained in any forward-looking statement to reflect events
or circumstances occurring after the date of this press release.


                     -Financial Tables to Follow-




Aehr Test Systems Reports Fourth Quarter Fiscal 2014 Financial Results
July 17, 2014
Page 3 of 5


                          AEHR TEST SYSTEMS AND SUBSIDIARIES
                    Condensed Consolidated Statements of Operations
                        (in thousands, except per share data)
                                   (unaudited)

Three Months Ended Year Ended ----------------------------- ------------------ May 31, Feb 28, May 31, May 31, May 31, 2014 2014 2013 2014 2013 -------- ------- -------- -------- -------- Net sales $ 5,370 $ 5,612 $ 3,262 $ 19,684 $ 16,488 Cost of sales 2,456 2,742 1,970 9,462 9,712 -------- -------- -------- -------- -------- Gross profit 2,914 2,870 1,292 10,222 6,776 -------- -------- -------- -------- -------- Operating expenses: Selling, general and administrative 1,685 1,701 1,504 6,323 6,872 Research and development 1,016 907 634 3,402 3,211 -------- -------- -------- -------- -------- Total operating expenses 2,701 2,608 2,138 9,725 10,083 -------- -------- -------- -------- -------- Income (loss) from operations 213 262 (846) 497 (3,307) Interest expense (5) (7) (6) (26) (49) Other income (expense), net 21 (21) 10 (64) (33) -------- -------- -------- -------- -------- Income (loss) before income tax benefit (expense) 229 234 (842) 407 (3,389) Income tax benefit (expense) 10 (22) (12) 15 (30) -------- -------- -------- -------- -------- Net income (loss) 239 212 (854) 422 (3,419) Less: Net income attributable to the noncontrolling interest -- -- -- -- -- -------- -------- -------- -------- -------- Net income (loss) attributable to Aehr Test Systems common shareholders $ 239 $ 212 $ (854) $ 422 $ (3,419) ======== ======== ======== ======== ======== Net income (loss) per share Basic $ 0.02 $ 0.02 $ (0.08) $ 0.04 $ (0.36) Diluted $ 0.02 $ 0.02 $ (0.08) $ 0.04 $ (0.36) Shares used in per share calculations: Basic 11,088 10,982 10,367 10,877 9,549 Diluted 12,255 12,277 10,367 11,889 9,549
-more- Aehr Test Systems Reports Fourth Quarter Fiscal 2014 Financial Results July 17, 2014 Page 4 of 5 AEHR TEST SYSTEMS AND SUBSIDIARIES Reconciliation of GAAP and Non-GAAP Results (in thousands, except per share data) (unaudited)
Three Months Ended Year Ended -------------------------- ----------------- May 31, Feb 28, May 31, May 31, May 31, 2014 2014 2013 2014 2013 -------- -------- --------- -------- -------- GAAP net income (loss) $ 239 $ 212 $ (854) $ 422 $(3,419) Stock-based compensation expense 204 235 174 829 601 -------- -------- -------- -------- -------- Non-GAAP net income (loss) $ 443 $ 447 $ (680) $ 1,251 $(2,818) ======== ======== ======== ======== ======== GAAP net income (loss) per diluted share $ 0.02 $ 0.02 $ (0.08) $ 0.04 $ (0.36) ======== ======== ======== ======== ======== Non-GAAP net income (loss) per diluted share $ 0.04 $ 0.04 $ (0.07) $ 0.11 $ (0.30) ======== ======== ======== ======== ======== Shares used in diluted shares calculation 12,255 12,277 10,367 11,889 9,549 ======== ======== ======== ======== ======== Shares used in non-GAAP diluted shares calculation 12,255 12,277 10,367 11,889 9,549 ======== ======== ======== ======== ========
______________________________________________________________________ Non-GAAP net income is a non-GAAP measure and should not be considered a replacement for GAAP results. Non-GAAP net income is a financial measure the Company uses to evaluate the underlying results and operating performance of the business. The limitation of this measure is that it excludes items that impact the Company's current period net income. This limitation is best addressed by using this measure in combination with net income (the most comparable GAAP measure). -more- Aehr Test Systems Reports Fourth Quarter Fiscal 2014 Financial Results July 17, 2014 Page 5 of 5 AEHR TEST SYSTEMS AND SUBSIDIARIES Condensed Consolidated Balance Sheets (in thousands, except per share data) (unaudited)
May 31, Feb 28, May 31, 2014 2014 2013 ----------- --------- -------- ASSETS Current assets: Cash and cash equivalents $ 1,809 $ 1,846 $ 2,324 Accounts receivable, net 3,390 3,378 2,632 Inventories 6,148 5,931 5,369 Prepaid expenses and other 326 399 276 -------- -------- -------- Total current assets 11,673 11,554 10,601 Property and equipment, net 474 311 301 Other assets 78 78 73 -------- -------- -------- Total assets $12,225 $11,943 $10,975 ======== ======== ======== LIABILITIES AND SHAREHOLDERS' EQUITY Current liabilities: Line of credit $ 777 $ 406 $ 1,101 Accounts payable 1,892 2,265 1,188 Accrued expenses 1,390 1,447 1,440 Customer deposits and deferred revenue, short-term 1,058 1,345 1,972 -------- -------- -------- Total current liabilities 5,117 5,463 5,701 Income tax payable 71 77 109 Deferred lease commitment, net of current portion 8 32 103 Deferred revenue, long-term -- 8 68 -------- -------- -------- Total liabilities 5,196 5,580 5,981 Aehr Test Systems Shareholders' equity 7,050 6,384 5,014 Noncontrolling interest (21) (21) (20) -------- -------- -------- Total shareholders' equity 7,029 6,363 4,994 -------- -------- -------- Total liabilities and shareholders' equity $12,225 $11,943 $10,975 ======== ======== ========
# # #

The following information was filed by Aehr Test Systems (AEHR) on Thursday, July 17, 2014 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release.


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549

FORM 10-K
(Mark One)
þ           Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the fiscal year ended May 31, 2014
or
o           Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
For the transition period from ________________ to ________________

Commission file number: 000-22893.

AEHR TEST SYSTEMS
(Exact name of registrant as specified in its charter)
 
 CALIFORNIA
 (State or other jurisdiction of  
incorporation or organization)
 94-2424084
(IRS Employer Identification Number)
   
 400 KATO TERRACE, FREMONT, CA
(Address of principal executive offices)
 94539
 (Zip Code)
                                                   
Registrant’s telephone number, including area code: (510) 623-9400

Securities registered pursuant to Section 12(b) of the Act:
Common stock, $0.01 par value
Name of each exchange on which registered:  The NASDAQ Capital Market
Securities registered pursuant to Section 12(g) of the Act:  None

     Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.  Yes  o  No þ

     Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Securities Act.  Yes  o  No þ

     Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

                            Yes  þ                No o

     Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

                             Yes  þ                 No o

     Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§229.405 of this chapter) is not contained herein, and will not be contained to the best of the registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.   þ
 
 


 
 
 
 
 

 
     Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act (Check one):
 
 Large accelerated filer    o   Accelerated filer   o
   
  Non-accelerated filer     o      Smaller reporting company   þ
(Do not check if a smaller reporting company)
 
            
     Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes  o  No þ
     
  The aggregate market value of the registrant’s common stock, par value $0.01 per share, held by non-affiliates of the registrant, based upon the closing price of $2.83 on November 30, 2013, as reported on the NASDAQ Capital Market, was $23,598,088.  For purposes of this disclosure, shares of common stock held by persons who hold more than 5% of the outstanding shares of common stock (other than such persons of whom the Registrant became aware only through the filing of a Schedule 13G filed with the Securities and Exchange Commission) and shares held by officers and directors of the Registrant have been excluded because such persons may be deemed to be affiliates. This determination of affiliate status is not necessarily conclusive for other purposes.

      The number of shares of registrant’s common stock, par value $0.01 per share, outstanding at July 31, 2014 was 11,465,718.

Documents Incorporated By Reference

    Certain information required by Part III of this Annual Report on Form 10-K is incorporated by reference from the Registrant’s proxy statement for the Annual Meeting of Shareholders to be held on October 21, 2014 (the “Proxy Statement”), which will be filed with the Securities and Exchange Commission within 120 days after the close of the registrant’s fiscal year ended May 31, 2014.
 
 
2
 
 

AEHR TEST SYSTEMS

FORM 10-K
FISCAL YEAR ENDED MAY 31, 2014

TABLE OF CONTENTS
 
PART I
4
9
15
15
15
15
     
PART II
     
16
18
20
27
28
51
51
51
     
PART III
 
52
52
52
52
52
     
PART IV
     
53
     
                 
57

 
3

 
 
    This Annual Report on Form 10-K contains forward-looking statements within the meaning of the Private Securities Litigation Act of 1995 which involve risks and uncertainties.  Unless the context requires otherwise, references in this Form 10-K to “Aehr Test,” the “Company,” “we,” “us” and “our” refer to Aehr Test Systems.  The Company’s actual results may differ materially from the results discussed in the forward-looking statements due to a number of factors, including those described herein and the documents incorporated herein by reference, and those factors described in Part I, Item 1A under “Risk Factors.”  These statements typically may be identified by the use of forward-looking words or phrases such as “believe,” “expect,” “intend,” “anticipate,” “should,” “planned,” “estimated” and “potential,” among others.  All forward-looking statements included in this document are based on our current expectations, and we assume no obligation to update any of these forward-looking statements.  We note that a variety of factors could cause actual results and experience to differ materially from the anticipated results or other expectations expressed in these forward-looking statements, including the risks and uncertainties that may affect the operations, performance, development and results of our businesses.  These risks include but are not limited to those factors identified in “Risk Factors” beginning on page 9 of this Annual Report on Form 10-K, those factors that we may from time to time identify in our periodic filings with the Securities and Exchange Commission, as well as other factors beyond our control.

PART I


THE COMPANY

    Aehr Test was incorporated in the state of California on May 25, 1977.  We develop, manufacture and sell systems which are designed to reduce the cost of testing and to perform reliability screening, or burn-in, of complex logic and memory devices.  These systems can be used to simultaneously perform parallel testing and burn-in of packaged integrated circuits, or ICs, singulated bare die or ICs still in wafer form.  Increased quality and reliability needs of the Automotive, Mobility and flash memory integrated circuit markets are driving additional testing requirements, capacity needs and opportunities for Aehr Test products in package and wafer level testing.  Leveraging its expertise as a long-time leading provider of burn-in equipment, with over 2,500 systems installed worldwide, the Company has developed and introduced several innovative product families, including the ABTSTM and FOXTM systems, the WaferPakTM cartridge and the DiePak® carrier.  The latest ABTS family of systems can perform test during burn-in of complex devices, such as digital signal processors, microprocessors, microcontrollers and systems-on-a-chip, and offers Individual Temperature Control for high-power advanced logic devices.  The FOX systems are full wafer contact parallel test and burn-in systems designed to make contact with all pads of a wafer simultaneously, thus enabling full wafer parallel test and burn-in.  The WaferPak cartridge includes a full-wafer probe card for use in testing wafers in FOX systems.  The DiePak carrier is a reusable, temporary package that enables IC manufacturers to perform cost-effective final test and burn-in of singulated bare die.
 
 INDUSTRY BACKGROUND

    Semiconductor manufacturing is a complex, multi-step process, and defects or weaknesses that may result in the failure of an integrated circuit may be introduced at any process step.  Failures may occur immediately or at any time during the operating life of an IC, sometimes after several months of normal use.  Semiconductor manufacturers rely on testing and reliability screening to identify and eliminate defects that occur during the manufacturing process.

    Testing and reliability screening involve multiple steps.  The first set of tests is typically performed by IC manufacturers before the processed semiconductor wafer is cut into individual die, in order to avoid the cost of packaging defective die into their packages.  This “wafer probe” testing can be performed on one or many die at a time, including testing the entire wafer at once.  After the die are packaged and before they undergo reliability screening, a short test is typically performed to detect packaging defects.  Most leading-edge microprocessors, microcontrollers, digital signal processors, and memory ICs then undergo an extensive reliability screening and stress testing procedure known as “burn-in” or “cycling.”  The burn-in process screens for early failures by operating the IC at elevated voltages and temperatures, up to 150 degrees Celsius (302 degrees Fahrenheit), for periods typically ranging from 2 to 48 hours.  A typical burn-in system can process thousands of ICs simultaneously.  After burn-in, the ICs undergo a final test process using automatic test equipment, or testers.  The cycling process screens flash memory devices for failure to meet write/erase cycling endurance requirements.

PRODUCTS

    The Company manufactures and markets full wafer contact test systems, test during burn-in systems, test fixtures, die carriers and related accessories.

 
4

 
    
  All of the Company’s systems are modular, allowing them to be configured with optional features to meet customer requirements.  Systems can be configured for use in production applications, where capacity, throughput and price are most important, or for reliability engineering and quality assurance applications, where performance and flexibility, such as extended temperature ranges, are essential.

    FULL WAFER CONTACT SYSTEMS

    The FOX-1 full wafer parallel test system, introduced in June 2005, is designed for massively parallel test in wafer sort.  The FOX-1 system is designed to make electrical contact to and test all of the die on a wafer in a single touchdown.  The FOX-1 test head and WaferPak contactor are compatible with industry-standard 300 mm wafer probers which provide the wafer handling and alignment automation for the FOX-1 system.  The FOX-1 pattern generator is designed to functionally test industry-standard memory such as flash and DRAMs, plus it is optimized to test memory or logic ICs that incorporate design for testability, or DFT, and built-in self-test, or BIST.  The FOX-1 pin electronics and per-device power supplies are tailored to full-wafer functional test.  The Company believes that the FOX-1 system can significantly reduce the cost of testing IC wafers.  The Company is currently in development of the next generation FOX system partially funded through a development agreement with a leading semiconductor manufacturer.   The system development is expected to be completed in calendar year 2014 and the Company has already received the first production order of this next generation system.

    The FOX-15 full wafer contact test and burn-in system, introduced in October 2007, is designed for use with wafers that require test and burn-in times typically measured in hours.  The FOX-15 is focused on parallel testing and burning-in up to 15 wafers at a time.  For high reliability applications, such as automotive, the FOX-15 system is a cost-effective solution for producing tested and burned-in die for use in multi-chip packages.  Using Known-Good Die, or KGD, which are fully burned-in and tested die, in multi-chip packages helps assure the reliability of the final product and lowers costs by increasing the yield of high-cost multi-chip packages.  Wafer-level burn-in and test enables lower cost production of KGD for multi-chip modules, 3-D stacked packages and systems-in-a-package.

    One of the key components of the FOX systems is the patented WaferPak cartridge system.  The WaferPak cartridge contains a full-wafer single-touchdown probe card which is easily removable from the system.  Traditional probe cards contact only a portion of the wafer, requiring multiple touchdowns to test the entire wafer.  The unique design is intended to accommodate a wide range of contactor technologies so that the contactor technology can evolve along with the changing requirements of the customer’s wafers.

    The full wafer contact systems product category accounted for approximately 42%, 31% and 53% of the Company’s net sales in fiscal 2014, 2013 and 2012, respectively.

    SYSTEMS FOR PACKAGED PARTS

    Test during burn-in, or TDBI, systems consist of several subsystems: pattern generation and test electronics, control software, network interface and environmental chamber.  The test pattern generator allows duplication of most of the functional tests performed by a traditional tester.  Pin electronics at each burn-in board, or BIB, position are designed to provide accurate signals to the ICs being tested and detect whether a device is failing the test.

    Devices being tested are placed on BIBs and loaded into environmental chambers which typically operate at temperatures from 25 degrees Celsius (77 degrees Fahrenheit) up to 150 degrees Celsius (302 degrees Fahrenheit) (optional chambers can produce temperatures as low as -55 degrees Celsius (-67 degrees Fahrenheit)).  A single BIB can hold up to several hundred ICs, and a production chamber holds up to 72 BIBs, resulting in thousands of memory or logic devices being tested in a single system.

    The Advanced Burn-in and Test System, or ABTS, was introduced in fiscal 2008.  The ABTS family of products is based on a completely new hardware and software architecture that is intended to address not only today’s devices, but also future devices for many years to come.   The ABTS system can test and burn-in both high-power logic and low-power ICs.  It can be configured to provide individual device temperature control for devices up to 70W or more and with up to 320 I/O channels.

    The MAX system family, the predecessor to the ABTS family, was designed for monitored burn-in of memory and logic devices.  It has 96 channels and holds 64 burn-in boards, each of which may hold up to 350 or more devices, resulting in a system capacity of up to 22,400 or more devices.  The output monitor feature allows the MAX system to perform functional tests of devices and it also supports BIST or other scan features.  The MAX4 extends the MAX system family to target devices that require higher current, and can provide up to 227 amps of current per BIB position.  All systems feature multi-tasking software which includes lot tracking and reporting software that are needed for
 
 
5

 
 
production and military applications.  The MAX system is nearing the end of its lifecycle and limited shipments are expected in the future.

    This packaged part systems product category accounted for approximately 57%, 68% and 43% of the Company’s net sales in fiscal 2014, 2013 and 2012, respectively.

    TEST FIXTURES

    The Company sells, and licenses others to manufacture and sell, custom-designed test fixtures for its systems.  The test fixtures include BIBs for the ABTS parallel test and burn-in system and for the MAX monitored burn-in system.  These test fixtures hold the devices undergoing test or burn-in and electrically connect the devices under test to the system electronics.  The capacity of each test fixture depends on the type of device being tested or burned-in, ranging from several hundred in memory production to as few as eight for high pin-count complex Application Specific Integrated Circuits, or ASICs, or microprocessor devices.  Test fixtures are sold both with new Aehr Test systems and for use with the Company’s installed base of systems.  Test fixtures are also available from third-party suppliers.

    The Company’s DiePak product line includes a family of reusable, temporary die carriers and associated sockets that enable the test and burn-in of bare die using the same test and burn-in systems used for packaged ICs.  DiePak carriers offer cost-effective solutions for providing KGD for most types of ICs, including memory, microcontroller and microprocessor devices.  The DiePak carrier consists of an interconnect substrate, which provides an electrical connection between the die pads and the socket contacts, and a mechanical support system.  The substrate is customized for each IC product.  The DiePak carrier comes in several different versions, designed to handle ICs ranging from 54 pin-count memory up to 320 pin-count microprocessors.
 
    The Company has received patents or applied for patents on certain features of the FOX, ABTS and MAX4 test fixtures.  The Company has licensed or authorized several other companies to provide MAX4 BIBs from which the Company receives royalties.  Royalties and revenue for the test fixtures product category accounted for less than 5% of net sales in fiscal 2014, 2013 and 2012.

CUSTOMERS

    The Company markets and sells its products throughout the world to semiconductor manufacturers, semiconductor contract assemblers, electronics manufacturers and burn-in and test service companies.

    Sales to the Company’s five largest customers accounted for approximately 90%, 81%, and 83% of its net sales in fiscal 2014, 2013 and 2012, respectively.  During fiscal 2014, Texas Instruments Incorporated, or Texas Instruments, and Spansion Inc., or Spansion, and Micronas GMBH accounted for approximately 40%, 30% and 12%, respectively, of the Company’s net sales.  During fiscal 2013, Texas Instruments and Spansion accounted for approximately 32% and 26%, respectively, of the Company’s net sales.  During fiscal 2012, Spansion and Texas Instruments accounted for approximately 40% and 22%, respectively, of the Company’s net sales.   No other customers accounted for more than 10% of the Company’s net sales for any of these periods.  The Company expects that sales of its products to a limited number of customers will continue to account for a high percentage of net sales for the foreseeable future.  In addition, sales to particular customers may fluctuate significantly from quarter to quarter.  Such fluctuations may result in changes in utilization of the Company’s facilities and resources.  The loss of or reduction or delay in orders from a significant customer or a delay in collecting or failure to collect accounts receivable from a significant customer could materially and adversely affect the Company’s business, financial condition and operating results.

MARKETING, SALES AND CUSTOMER SUPPORT

    The Company has sales and service operations in the United States, Japan, Germany and Taiwan, and has established a network of distributors and sales representatives in certain key parts of the world.  See “REVENUE RECOGNITION” in Item 7 under “Management’s Discussion and Analysis of Financial Condition and Results of Operations” for a further discussion of the Company’s relationship with distributors, and its effects on revenue recognition.

    The Company’s customer service and support program includes system installation, system repair, applications engineering support, spare parts inventories, customer training and documentation.  The Company has both applications engineering and field service personnel located at the corporate headquarters in Fremont, California, at several locations in Texas and at the Company’s subsidiaries in Japan, Germany and Taiwan.  The Company’s distributors provide applications and field service support in other parts of the world.  The Company customarily provides a warranty on its products.  The Company offers service contracts on its systems directly and through its subsidiaries, distributors and representatives.  The Company maintains customer support personnel in the Philippines and China.  The Company
 
 
6

 
 
believes that maintaining a close relationship with customers and providing them with ongoing engineering support improves customer satisfaction and will provide the Company with a competitive advantage in selling its products to the Company’s customers.

BACKLOG

    At May 31, 2014, the Company’s backlog was $6.0 million compared with $9.1 million at May 31, 2013.  The Company’s backlog consists of product orders for which confirmed purchase orders have been received and which are scheduled for shipment within 12 months.  Due to the possibility of customer changes in delivery schedules or cancellations and potential delays in product shipments or development projects, the Company’s backlog as of a particular date may not be indicative of net sales for any succeeding period.

RESEARCH AND PRODUCT DEVELOPMENT

    The Company historically has devoted a significant portion of its financial resources to research and development programs and expects to continue to allocate significant resources to these efforts.  Certain research and development expenditures related to non-recurring engineering milestones have been transferred to cost of goods sold, reducing research and development expenses.  The Company’s research and development expenses during fiscal 2014, 2013 and 2012 were $3.4 million, $3.2 million and $4.2 million, respectively.

    The Company conducts ongoing research and development to design new products and to support and enhance existing product lines.  Building upon the expertise gained in the development of its existing products, the Company has developed the FOX family of systems for performing test and burn-in of entire processed wafers, rather than individual die or packaged parts.  During the first quarter of fiscal 2013, the Company entered into an agreement with a customer to develop a next generation FOX system.   This new FOX system is designed to provide the customer with increased test flexibility and capability at a significantly lower cost of test than alternative solutions while also expanding the markets addressed by our FOX full wafer test products.  The Company is developing enhancements to the ABTS family of products, intended to improve the capability and performance for testing and burn-in of future generation ICs and provide the flexibility in a wide variety of applications from logic to memory.  

MANUFACTURING

    The Company assembles its products from components and parts manufactured by others, including environmental chambers, power supplies, metal fabrications, printed circuit assemblies, ICs, burn-in sockets, high-density interconnects, wafer contactors and interconnect substrates.  Final assembly and testing are performed within the Company’s facilities.  The Company’s strategy is to use in-house manufacturing only when necessary to protect a proprietary process or when a significant improvement in quality, cost or lead time can be achieved.  The Company’s principal manufacturing facility is located in Fremont, California.  The Company’s facility in Utting, Germany provides limited manufacturing and product customization.

    The Company relies on subcontractors to manufacture many of the components and subassemblies used in its products.  The Company’s FOX and ABTS systems, WaferPak cartridges and DiePak carriers contain several components, including environmental chambers, power supplies, high-density interconnects, wafer contactors, signal distribution substrates and certain ICs, that are currently supplied by only one or a limited number of suppliers.  The Company’s reliance on subcontractors and single source suppliers involves a number of significant risks, including the loss of control over the manufacturing process, the potential absence of adequate capacity and reduced control over delivery schedules, manufacturing yields, quality and costs.  In the event that any significant subcontractor or single source supplier becomes unable or unwilling to continue to manufacture subassemblies, components or parts in required volumes, the Company will have to identify and qualify acceptable replacements.  The process of qualifying subcontractors and suppliers could be lengthy, and no assurance can be given that any additional sources would be available to the Company on a timely basis.  Any delay, interruption or termination of a supplier relationship could adversely affect our ability to deliver products, which would harm our operating results.

COMPETITION

    The semiconductor equipment industry is intensely competitive.  Significant competitive factors in the semiconductor equipment market include price, technical capabilities, quality, flexibility, automation, cost of ownership, reliability, throughput, product availability and customer service.  In each of the markets it serves, the Company faces competition from established competitors and potential new entrants, many of which have greater financial, engineering, manufacturing and marketing resources than the Company.

 
7

 
    
  The Company’s FOX full wafer contact systems face competition from larger systems manufacturers that have significant technological know-how and manufacturing capability.  Competing suppliers of full wafer contact systems include Advantest Corporation, Teradyne Inc., Micronics Japan Co., Ltd., and Delta V Instruments, Incorporated.

    The Company’s ABTS and MAX TDBI systems have faced and are expected to continue to face increasingly severe competition, especially from several regional, low-cost manufacturers and from systems manufacturers that offer higher power dissipation per device under test.  Some users of such systems, such as independent test labs, build their own burn-in systems, while others, particularly large IC manufacturers in Asia, acquire burn-in systems from captive or affiliated suppliers.  The market for burn-in systems is highly fragmented, with many domestic and international suppliers.  Competing suppliers of burn-in and functional test systems include Dong-Il Corporation, Micro Control Company, Incal Technology, Advantest Corporation, UniTest Inc. and Blue Engineering Inc.

    The Company’s WaferPak products are facing and are expected to face increasing competition.  Several companies have developed or are developing full-wafer and single-touchdown probe cards.  As the full-wafer test market develops, the Company expects that other competitors will emerge.  The primary competitive factors in this market are cost, performance, reliability and assured supply.  Competing suppliers of full-wafer probe cards include FormFactor, Inc., Japan Electronic Materials Corporation and Micronics Japan Co., Ltd.

    The Company’s test fixture products face numerous regional competitors.  There are limited barriers to entry into the BIB market, and as a result, many companies design and manufacture BIBs, including BIBs for use with the Company’s ABTS and MAX systems.  The Company has granted royalty-bearing licenses to several companies to make BIBs for use with the Company’s MAX4 systems and the Company may grant additional licenses as well.  Sales of MAX4 BIBs by licensees result in royalties to the Company.

    The Company expects that its DiePak products will face significant competition.  The Company believes that several companies have developed or are developing products which are intended to enable test and burn-in of bare die.  As the bare die market develops, the Company expects that other competitors will emerge.  The DiePak products also face severe competition from other alternative test solutions.  The Company expects that the primary competitive factors in this market will be cost, performance, reliability and assured supply.  Suppliers with products that compete with our DiePak products include Yamaichi Electronics Co., Ltd.

    The Company expects its competitors to continue to improve the performance of their current products and to introduce new products with improved price and performance characteristics.  New product introductions by the Company’s competitors or by new market entrants could cause a decline in sales or loss of market acceptance of the Company’s products.  The Company has observed price competition in the systems market, particularly with respect to its less advanced products.  Increased competitive pressure could also lead to intensified price-based competition, resulting in lower prices which could adversely affect the Company’s operating margins and results.  The Company believes that to remain competitive it must invest significant financial resources in new product development and expand its customer service and support worldwide.  There can be no assurance that the Company will be able to compete successfully in the future.

PROPRIETARY RIGHTS

    The Company relies primarily on the technical and creative ability of its personnel, its proprietary software, and trade secrets and copyright protection, rather than on patents, to maintain its competitive position.  The Company’s proprietary software is copyrighted and licensed to the Company’s customers.  At May 31, 2014 the Company held forty issued United States patents with expiration date ranges from 2014 to 2029 and had several additional United States patent applications and foreign patent applications pending.

    The Company’s ability to compete successfully is dependent in part upon its ability to protect its proprietary technology and information.  Although the Company attempts to protect its proprietary technology through patents, copyrights, trade secrets and other measures, there can be no assurance that these measures will be adequate or that competitors will not be able to develop similar technology independently.  Further, there can be no assurance that claims allowed on any patent issued to the Company will be sufficiently broad to protect the Company’s technology, that any patent will be issued to the Company from any pending application or that foreign intellectual property laws will protect the Company’s intellectual property.  Litigation may be necessary to enforce or determine the validity and scope of the Company’s proprietary rights, and there can be no assurance that the Company’s intellectual property rights, if challenged, will be upheld as valid.  Any such litigation could result in substantial costs and diversion of resources and could have a material adverse effect on the Company’s business, financial condition and operating results, regardless of the outcome of the litigation.  In addition, there can be no assurance that any of the patents issued to the Company will not be challenged, invalidated or circumvented or that the rights granted thereunder will provide competitive advantages
 
 
 
8

 
 
 to the Company.  Also, there can be no assurance that the Company will have the financial resources to defend its patents from infringement or claims of invalidity.

    There are currently no pending claims against the Company regarding infringement of any patents or other intellectual property rights of others.  However, the Company may receive communications from third parties asserting intellectual property claims against the Company.  Such claims could include assertions that the Company’s products infringe, or may infringe, the proprietary rights of third parties, requests for indemnification against such infringement or suggest the Company may be interested in acquiring a license from such third parties.  There can be no assurance that any such claim made in the future will not result in litigation, which could involve significant expense to the Company, and, if the Company is required or deems it appropriate to obtain a license relating to one or more products or technologies, there can be no assurance that the Company would be able to do so on commercially reasonable terms, or at all.

EMPLOYEES

    As of May 31, 2014, the Company, including its two foreign subsidiaries and one branch office, employed 76 persons collectively, on a full-time basis, of whom 21 were engaged in research, development and related engineering, 20 were engaged in manufacturing, 23 were engaged in marketing, sales and customer support and 12 were engaged in general administration and finance functions.  In addition, the Company from time to time employs a number of contractors and part-time employees, particularly to perform customer support and manufacturing.  The Company’s success is in part dependent on its ability to attract and retain highly skilled workers, who are in high demand.  None of the Company’s employees are represented by a union and the Company has never experienced a work stoppage.  The Company’s management considers its relations with its employees to be good.

BUSINESS SEGMENT DATA AND GEOGRAPHIC AREAS

    The Company operates in a single business segment, the designing, manufacturing and marketing of advanced test and burn-in products to the semiconductor manufacturing industry in several geographic areas.  Selected financial information, including net sales and property and equipment, net for each of the last three fiscal years, by geographic area is included in Part II, Item 8, Note 13 “Segment Information” and certain risks related to such operations are discussed in Part I, Item 1A, under the heading “We sell our products and services worldwide, and our business is subject to risks inherent in conducting business activities in geographic regions outside of the United States.”

AVAILABLE INFORMATION

    The Company’s common stock trades on the NASDAQ Capital Market under the symbol “AEHR.”  The Company’s annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and amendments to these reports that are filed with the United States Securities and Exchange Commission, or SEC, pursuant to Section 13(a) or 15(d) of the Exchange Act, are available free of charge through the Company’s website at www.aehr.com as soon as reasonably practicable after we electronically file them with, or furnish them to the SEC.

    The public may read and copy any materials filed by the Company with the SEC at the SEC’s Public Reference Room at 100 F Street, NE, Washington, DC 20549.  The public may obtain information on the operations of the Public Reference Room by calling the SEC at 1-800-SEC-0330.  The SEC maintains an Internet site, http://www.sec.gov, that contains reports, proxy and information statements and other information regarding issuers that file electronically with the SEC.

    In addition, information regarding the Company’s code of conduct and ethics and the charters of its Audit, Compensation and Nominating and Governance Committees, are available free of charge on the Company’s website listed above.


    You should carefully consider the risks described below. These risks are not the only risks that we may face. Additional risks and uncertainties that we are unaware of, or that we currently deem immaterial, also may become important factors that affect us. If any of the following risks occur, our business, financial condition or results of operations could be materially and adversely affected which could cause our actual operating results to differ materially from those indicated or suggested by forward-looking statements made in this Annual Report on Form 10-K or presented elsewhere by management from time to time.


 
9

 

Periodic economic and semiconductor industry downturns could negatively affect our business, results of operations and financial condition.

    Periodic global economic and semiconductor industry downturns have negatively affected and could continue to negatively affect our business, results of operations, and financial condition.  Financial turmoil in the banking system and financial markets has resulted, and may result in the future, in a tightening of the credit markets, disruption in the financial markets and global economy downturn.  These events may contribute to significant slowdowns in the industry in which we operate.   Difficulties in obtaining capital and deteriorating market conditions can pose the risk that some of our customers may not be able to obtain necessary financing on reasonable terms, which could result in lower sales for the Company.  Customers with liquidity issues may lead to additional bad debt expense for the Company.  For example, as a result of Spansion declaring bankruptcy in Japan and the U.S. during fiscal 2009, the Company subsequently recorded a $13.7 million provision for bad debts.  A recurrence of these or similar conditions may also affect our key suppliers, which could impact their ability to deliver parts and result in delays in deliveries of our products.

    Turmoil in the international financial markets has resulted, and may result in the future, in dramatic currency devaluations, stock market declines, restriction of available credit and general financial weakness.  In addition, flash, DRAM and other memory device prices have historically declined, and will likely do so again in the future.  These developments may affect us in several ways.  We believe that many international semiconductor manufacturers limited their capital spending in calendar 2009 and again in calendar 2012 and 2013, and that the uncertainty of the semiconductor market may cause some manufacturers in the future to further delay capital spending plans.  Economic conditions may also affect the ability of our customers to meet their payment obligations, resulting in cancellations or deferrals of existing orders and limiting additional orders.  In addition, some governments have subsidized portions of fabrication facility construction, and financial turmoil may reduce these governments’ willingness to continue such subsidies.  Such developments could have a material adverse effect on our business, financial condition and results of operations.

    The recent economic conditions and uncertainty about future economic conditions make it challenging for us to forecast our operating results, make business decisions, and identify the risks that may affect our business, financial condition and results of operations.  If such conditions recur, and we are not able to timely and appropriately adapt to changes resulting from the difficult macroeconomic environment, our business, financial condition or results of operations may be materially and adversely affected.

If we are not able to reduce our operating expenses sufficiently during periods of weak revenue, or if we utilize significant amounts of cash to support operating losses, we may erode our cash resources and may not have sufficient cash to operate our business.

    In prior years, in the face of a downturn in our business and a decline in our net sales, we implemented a variety of cost controls and restructured our operations with the goal of reducing our operating costs to position ourselves to more effectively meet the needs of the then weak market for test and burn-in equipment.  While we took significant steps in fiscal 2009 to minimize our expense levels and to increase the likelihood that we would have sufficient cash to support operations during the downturn, from fiscal 2009 through fiscal 2013 we experienced operating losses.  Should a business downturn recur, and if we are unable to reduce our operating expenses sufficiently, we may require additional debt or equity financing to meet working capital or capital expenditure needs.  While we believe our existing cash balance, together with cash flows from operations, as well as funds available through our working capital credit facility, will be adequate to meet our working capital and capital equipment requirements through fiscal 2015, we cannot determine with certainty that, if needed, we will be able to raise additional funding through either equity or debt financing under these circumstances or on what terms such financing would be available.
    
We generate a large portion of our sales from a small number of customers.  If we were to lose one or more of our large customers, operating results could suffer dramatically.

    The semiconductor manufacturing industry is highly concentrated, with a relatively small number of large semiconductor manufacturers and contract assemblers accounting for a substantial portion of the purchases of semiconductor equipment.  Sales to the Company’s five largest customers accounted for approximately 90%, 81%, and 83% of its net sales in fiscal 2014, 2013, and 2012, respectively.  During fiscal 2014, Texas Instruments, Spansion and Micronas GMBH accounted for approximately 40%, 30% and 12%, respectively, of the Company’s net sales.  During fiscal 2013, Texas Instruments and Spansion accounted for approximately 32% and 26%, respectively, of the Company’s net sales.  During fiscal 2012, Spansion and Texas Instruments accounted for approximately 40% and 22%, respectively, of the Company’s net sales.  No other customers accounted for more than 10% of the Company’s net sales for any of these periods.

 
10

 
    
  We expect that sales of our products to a limited number of customers will continue to account for a high percentage of net sales for the foreseeable future.  In addition, sales to particular customers may fluctuate significantly from quarter to quarter.  The loss of, reduction or delay in an order, or orders from a significant customer, or a delay in collecting or failure to collect accounts receivable from a significant customer could adversely affect our business, financial condition and operating results.  For example, during fiscal 2009 Spansion, our largest customer at the time, declared bankruptcy in Japan and in the U.S. and subsequently placed lower levels of orders with the Company, which caused our net sales to drop dramatically and impacted the Company’s ability to collect on accounts receivable.

A substantial portion of our net sales is generated by relatively small volume, high value transactions.

    We derive a substantial portion of our net sales from the sale of a relatively small number of systems which typically range in purchase price from approximately $200,000 to over $1 million per system.  As a result, the loss or deferral of a limited number of system sales could have a material adverse effect on our net sales and operating results in a particular period.  All customer purchase orders are subject to cancellation or rescheduling by the customer with limited penalties, and, therefore, backlog at any particular date is not necessarily indicative of actual sales for any succeeding period.  From time to time, cancellations and rescheduling of customer orders have occurred, and delays by our suppliers in providing components or subassemblies to us have caused delays in our shipments of our own products.  There can be no assurance that we will not be materially adversely affected by future cancellations or rescheduling.  For non-standard products where we have not effectively demonstrated the ability to meet specifications in the customer environment, we defer revenue until we have met such customer specifications.  Any delay in meeting customer specifications could have a material adverse effect on our operating results.  A substantial portion of net sales typically are realized near the end of each quarter.  A delay or reduction in shipments near the end of a particular quarter, due, for example, to unanticipated shipment rescheduling, cancellations or deferrals by customers, customer credit issues, unexpected manufacturing difficulties experienced by us or delays in deliveries by suppliers, could cause net sales in a particular quarter to fall significantly below our expectations.

We rely on increasing market acceptance for our FOX system, and we may not be successful in attracting new customers or maintaining our existing customers.

    A principal element of our business strategy is to increase our presence in the test equipment market through system sales in our FOX wafer-level test and burn-in product family.  The FOX system is designed to simultaneously functionally test and burn-in all of the die on a wafer on a single touchdown.  The market for the FOX systems is in the early stages of development.  Market acceptance of the FOX system is subject to a number of risks.  Before a customer will incorporate the FOX system into a production line, lengthy qualification and correlation tests must be performed.  We anticipate that potential customers may be reluctant to change their procedures in order to transfer burn-in and test functions to the FOX system.  Initial purchases are expected to be limited to systems used for these qualifications and for engineering studies.  Market acceptance of the FOX system also may be affected by a reluctance of IC manufacturers to rely on relatively small suppliers such as us.  As is common with new complex products incorporating leading-edge technologies, we may encounter reliability, design and manufacturing issues as we begin volume production and initial installations of FOX systems at customer sites.  The failure of the FOX system to achieve increased market acceptance would have a material adverse effect on our future operating results, long-term prospects and our stock price.

We rely on continued market acceptance of our ABTS system and our ability to complete certain enhancements.

    Continued market acceptance of the ABTS family, first introduced in fiscal 2008, is subject to a number of risks.  It is important that we achieve customer acceptance, customer satisfaction and increased market acceptance as we add new features and enhancements to the ABTS product.  To date, the Company has shipped ABTS systems to customers worldwide for use in both reliability and production applications.  The failure of the ABTS family to maintain revenues at or above current levels would have a material adverse effect on our future operating results.

We may experience increased costs associated with new product introductions.

    As is common with new complex products incorporating leading-edge technologies, we have encountered reliability, design and manufacturing issues as we began volume production and initial installations of certain products at customer sites.  Some of these issues in the past have been related to components and subsystems supplied to us by third parties who have in some cases limited the ability of us to address such issues promptly.  This process in the past required and in the future is likely to require us to incur un-reimbursed engineering expenses and to experience larger than anticipated warranty claims which could result in product returns.  In the early stages of product development there can be no assurance that we will discover any reliability, design and manufacturing issues or, that if such issues arise, that they can be resolved to the customers’ satisfaction or that the resolution of such problems will not cause us to incur significant development costs or warranty expenses or to lose significant sales opportunities.
 
 
 
11

 
 
We sell our products and services worldwide, and our business is subject to risks inherent in conducting business activities in geographic regions outside of the United States.

    Approximately 56%, 55%, and 38% of our net sales for fiscal 2014, 2013 and 2012, respectively, were attributable to sales to customers for delivery outside of the United States.  We operate a sales, service and limited manufacturing organization in Germany and a sales and service organization in Japan and Taiwan.  We expect that sales of products for delivery outside of the United States will continue to represent a substantial portion of our future net sales.  Our future performance will depend, in significant part, upon our ability to continue to compete in foreign markets which in turn will depend, in part, upon a continuation of current trade relations between the United States and foreign countries in which semiconductor manufacturers or assemblers have operations.  A change toward more protectionist trade legislation in either the United States or such foreign countries, such as a change in the current tariff structures, export compliance or other trade policies, could adversely affect our ability to sell our products in foreign markets.  In addition, we are subject to other risks associated with doing business internationally, including longer receivable collection periods and greater difficulty in accounts receivable collection, the burden of complying with a variety of foreign laws, difficulty in staffing and managing global operations, risks of civil disturbance or other events which may limit or disrupt markets, international exchange restrictions, changing political conditions and monetary policies of foreign governments.

    Approximately 96%, 3% and 1% of our net sales for fiscal 2014 were denominated in U.S. Dollars, Euros and Japanese Yen, respectively.  Although the percentages of net sales denominated in Euros and Japanese Yen were small in fiscal 2014, they have been larger in the past and could become significant again in the future.  A large percentage of net sales to European customers are denominated in U.S. Dollars, but sales to many Japanese customers are denominated in Japanese Yen.  Because a substantial portion of our net sales is from sales of products for delivery outside the United States, an increase in the value of the U.S. Dollar relative to foreign currencies would increase the cost of our products compared to products sold by local companies in such markets.  In addition, since the price is determined at the time a purchase order is accepted, we are exposed to the risks of fluctuations in the U.S. Dollar exchange rate during the lengthy period from the date a purchase order is received until payment is made.  This exchange rate risk is partially offset to the extent our foreign operations incur expenses in the local currency.  To date, we have not invested in instruments designed to hedge currency risks.  Our operating results could be adversely affected by fluctuations in the value of the U.S. Dollar relative to other currencies.

The Company’s business operations could be negatively impacted by earthquakes or other natural disasters.

      The March 2011 Japanese earthquake and resulting tsunami seriously affected many companies in Japan, including some of our customers.  Some of our customers delayed capital equipment purchases as a result of the disaster. The disaster also negatively impacted the Japanese economy as a whole, which could further impact the Company's future business prospects in Japan.
 
  Natural disasters may impact our ability to manufacture products in the event our facility is damaged, or if operations are disrupted at a major supplier.  The demand for our products may be negatively affected if a natural disaster impacts one or more of our significant customers. These events may seriously damage our ability to conduct business.

Our industry is subject to rapid technological change and our ability to remain competitive depends on our ability to introduce new products in a timely manner.

    The semiconductor equipment industry is subject to rapid technological change and new product introductions and enhancements.  Our ability to remain competitive depends in part upon our ability to develop new products and to introduce them at competitive prices and on a timely and cost-effective basis.  Our success in developing new and enhanced products depends upon a variety of factors, including product selection, timely and efficient completion of product design, timely and efficient implementation of manufacturing and assembly processes, product performance in the field and effective sales and marketing.  Because new product development commitments must be made well in advance of sales, new product decisions must anticipate both future demand and the technology that will be available to supply that demand.  Furthermore, introductions of new and complex products typically involve a period in which design, engineering and reliability issues are identified and addressed by our suppliers and by us.  There can be no assurance that we will be successful in selecting, developing, manufacturing and marketing new products that satisfy market demand.  Any such failure would materially and adversely affect our business, financial condition and results of operations.

    Because of the complexity of our products, significant delays can occur between a product’s introduction and the commencement of the volume production of such product.  We have experienced, from time to time, significant delays in the introduction of, and technical and manufacturing difficulties with, certain of our products and may experience delays and technical and manufacturing difficulties in future introductions or volume production of our new products.
 
 
12

 
    
 
Our inability to complete new product development, or to manufacture and ship products in time to meet customer requirements would materially adversely affect our business, financial condition and results of operations.

Our dependence on subcontractors and sole source suppliers may prevent us from delivering our products on a timely basis and expose us to intellectual property infringement.

    We rely on subcontractors to manufacture many of the components or subassemblies used in our products.  Our FOX and ABTS systems, WaferPak contactors and DiePak carriers contain several components, including environmental chambers, power supplies, high-density interconnects, wafer contactors, signal distribution substrates and certain ICs that are currently supplied by only one or a limited number of suppliers.  Our reliance on subcontractors and single source suppliers involves a number of significant risks, including the loss of control over the manufacturing process, the potential absence of adequate capacity and reduced control over delivery schedules, manufacturing yields, quality and costs.  In the event that any significant subcontractor or single source supplier is unable or unwilling to continue to manufacture subassemblies, components or parts in required volumes, we would have to identify and qualify acceptable replacements.  The process of qualifying subcontractors and suppliers could be lengthy, and no assurance can be given that any additional sources would be available to us on a timely basis.  Any delay, interruption or termination of a supplier relationship could adversely affect our ability to deliver products, which would harm our operating results.

    Our suppliers manufacture components, tooling, and provide engineering services.  During this process, our suppliers are allowed access to intellectual property of the Company.  While the Company maintains patents to protect from intellectual property infringement, there can be no assurance that technological information gained in the manufacture of our products will not be used to develop a new product, improve processes or techniques which compete against our products.  Litigation may be necessary to enforce or determine the validity and scope of our proprietary rights, and there can be no assurance that our intellectual property rights, if challenged, will be upheld as valid.

Future changes in semiconductor technologies may make our products obsolete.

    Future improvements in semiconductor design and manufacturing technology may reduce or eliminate the need for our products.  For example, improvements in semiconductor process technology and improvements in conventional test systems, such as reduced cost or increased throughput, may significantly reduce or eliminate the market for one or more of our products.  If we are not able to improve our products or develop new products or technologies quickly enough to maintain a competitive position in our markets, our business may decline.

Semiconductor business cycles are not easily predicted and there is always the risk of cancellations and rescheduling which could have a material adverse effect on our operating results.

    Our operating results depend primarily upon the capital expenditures of semiconductor manufacturers, semiconductor contract assemblers and burn-in and test service companies worldwide, which in turn depend on the current and anticipated market demand for ICs. The semiconductor equipment manufacturing industry has historically been subject to a relatively high rate of purchase order cancellation by customers as compared to other high technology industry sectors. Manufacturing companies who are the customers of semiconductor equipment companies frequently revise, postpone and cancel capital facility expansion plans. In such cases, semiconductor equipment companies may experience a significant rate of cancellations or rescheduling of purchase orders. There can be no assurance that we will not be materially adversely affected by future cancellations or rescheduling of purchase orders.
  
The Company may not meet the listing requirements of the NASDAQ markets which could cause our stock to be delisted.

    Pursuant to the listing requirements of NASDAQ, if a company’s stock price is below $1.00 per share for 30 consecutive trading days , NASDAQ will notify the company that it is no longer in compliance with the NASDAQ Bid Price Rule listing qualification.  If a company is not in compliance with the Bid Price Rule, the company will have 180 calendar days to regain compliance.  The company may regain compliance with the Bid Price Rule if the bid price of the common stock closes at $1.00 per share or more for a minimum of 10 consecutive business days at any time during the 180 day cure period.  On November 2, 2011, the Company received notice from NASDAQ that it was no longer in compliance with the Bid Price Rule.  The Company regained compliance on April 16, 2012.  On December 26, 2012, the Company received notice from NASDAQ that it was no longer in compliance with the Bid Price Rule.  The Company subsequently regained compliance on April 3, 2013.

    On January 18, 2011 the Company received notice from NASDAQ that it was no longer in compliance with NASDAQ’s Listing Rule 5450(b)(1)(A), which specifies that an issuer must maintain stockholders’ equity of at least $10 million.  On March 21, 2011 the Company submitted an application to NASDAQ to transfer the listing of its company stock from the NASDAQ Global Market to the NASDAQ Capital Market.  On March 24, 2011 the Company received a
 
 
13

 
 
letter from NASDAQ informing it that the NASDAQ Listing Qualifications Staff had granted the Company’s request to transfer the listing of its common stock to the NASDAQ Capital Market, effective at the opening of business on March 28, 2011.  The Bid Price Rule is also a listing requirement of the NASDAQ Capital Market.
 
     There can be no assurance that the Company will remain in compliance with the Bid Price Rule, and that it will maintain compliance with the other listing requirements of the NASDAQ Capital Market, or that it will not be delisted.

Our stock price may fluctuate.

    The price of our common stock has fluctuated in the past and may fluctuate significantly in the future.  We believe that factors such as announcements of developments related to our business, fluctuations in our operating results, failure to meet securities analysts’ expectations, general conditions in the semiconductor and semiconductor equipment industries as well as the worldwide economy, announcement of technological innovations, new systems or product enhancements by us or our competitors, fluctuations in the level of cooperative development funding, acquisitions, changes in governmental regulations, developments in patents or other intellectual property rights and changes in our relationships with customers and suppliers could cause the price of our common stock to fluctuate substantially.  In addition, in recent years the stock market in general, and the market for small capitalization and high technology stocks in particular, have experienced extreme price fluctuations which have often been unrelated to the operating performance of the affected companies.  Such fluctuations could adversely affect the market price of our common stock.

We depend on our key personnel and our success depends on our ability to attract and retain talented employees.

    Our success depends to a significant extent upon the continued service of Gayn Erickson, our President and Chief Executive Officer, as well as other executive officers and key employees.  We do not maintain key person life insurance for our benefit on any of our personnel, and none of our employees are subject to a non-competition agreement with us.  The loss of the services of any of our executive officers or a group of key employees could have a material adverse effect on our business, financial condition and operating results.  Our future success will depend in significant part upon our ability to attract and retain highly skilled technical, management, sales and marketing personnel.  There is a limited number of personnel with the requisite skills to serve in these positions, and it has become increasingly difficult for us to hire such personnel.  Competition for such personnel in the semiconductor equipment industry is intense, and there can be no assurance that we will be successful in attracting or retaining such personnel.  Changes in management could disrupt our operations and adversely affect our operating results.

We may be subject to litigation relating to intellectual property infringement which would be time-consuming, expensive and a distraction from our business.

    If we do not adequately protect our intellectual property, competitors may be able to use our proprietary information to erode our competitive advantage, which could harm our business and operating results.  Litigation may be necessary to enforce or determine the validity and scope of our proprietary rights, and there can be no assurance that our intellectual property rights, if challenged, will be upheld as valid.  Such litigation could result in substantial costs and diversion of resources and could have a material adverse effect on our operating results, regardless of the outcome of the litigation.  In addition, there can be no assurance that any of the patents issued to us will not be challenged, invalidated or circumvented or that the rights granted thereunder will provide competitive advantages to us.

    There are no pending claims against us regarding infringement of any patents or other intellectual property rights of others.  However, in the future we may receive communications from third parties asserting intellectual property claims against us.  Such claims could include assertions that our products infringe, or may infringe, the proprietary rights of third parties, requests for indemnification against such infringement or suggestions that we may be interested in acquiring a license from such third parties.  There can be no assurance that any such claim will not result in litigation, which could involve significant expense to us, and, if we are required or deem it appropriate to obtain a license relating to one or more products or technologies, there can be no assurance that we would be able to do so on commercially reasonable terms, or at all.

While we believe we have complied with all applicable environmental laws, our failure to do so could adversely affect our business as a result of having to pay substantial amounts in damages or fees.

    Federal, state and local regulations impose various controls on the use, storage, discharge, handling, emission, generation, manufacture and disposal of toxic and other hazardous substances used in our operations.  We believe that our activities conform in all material respects to current environmental and land use regulations applicable to our operations and our current facilities, and that we have obtained environmental permits necessary to conduct our business.  Nevertheless, failure to comply with current or future regulations could result in substantial fines, suspension
 
 
 
14

 
 
of production, alteration of our manufacturing processes or cessation of operations.  Such regulations could require us to acquire expensive remediation equipment or to incur substantial expenses to comply with environmental regulations.  Any failure to control the use, disposal or storage of or adequately restrict the discharge of, hazardous or toxic substances could subject us to significant liabilities.

While we believe we currently have adequate internal control over financial reporting, we are required to assess our internal control over financial reporting on an annual basis and any future adverse results from such assessment could result in a loss of investor confidence in our financial reports and have an adverse effect on our stock.

    Pursuant to Section 404 of the Sarbanes-Oxley Act of 2002, we must include in our Annual Report on Form 10-K a report of management on the effectiveness of our internal control over financial reporting.  If we fail to maintain effective internal control over financial reporting, or management does not timely assess the adequacy of such internal control, we could be subject to regulatory sanctions and the investing public’s perception of the Company may decline.


    None.


    The Company’s principal administrative and production facilities are located in Fremont, California, in a 51,289 square foot building.  The term of the Company’s current lease ends on June 30, 2015.  The Company has an option to extend the lease for an additional period at rates to be determined.  The Company’s facility in Japan was located in Tokyo in a 4,294 square foot building until this lease was cancelled on June 30, 2013.  The Company moved its facility in Japan to a 418 square foot office in Tokyo under a lease which expires in June, 2016.  The Company also maintains a 1,585 square foot warehouse in Yamanashi under a lease which expires in November, 2015.  The Company leases a sales and support office in Utting, Germany.  The lease, which began February 1, 1992 and expires on January 31, 2015, contains an automatic twelve months renewal, at rates to be determined, if no notice is given prior to six months from expiry.  The Company’s and its subsidiaries’ annual rental payments currently aggregate $562,000.  The Company periodically evaluates its global operations and facilities to bring its capacity in line with demand and to provide cost efficient services for its customers.  In prior years, through this process, the Company has moved from certain facilities that exceeded the capacity required to satisfy its needs.  The Company believes that its existing facilities are adequate to meet its current and reasonably foreseeable requirements. The Company regularly evaluates its expected future facilities requirements and believes that alternate facilities would be available if needed.


    None.


    Not Applicable

 
15

 
 
PART II


    The Company’s common stock is publicly traded on the NASDAQ Capital Market under the symbol “AEHR”.  The following table sets forth, for the periods indicated, the high and low sale prices for the common stock on such market.  These quotations represent prices between dealers and do not include retail markups, markdowns or commissions and may not necessarily represent actual transactions.

   
High
   
Low
 
Fiscal 2014:
           
 First quarter ended August 31, 2013
  $ 2.05     $ 1.24  
 Second quarter ended November 30, 2013
    3.59       1.46  
 Third quarter ended February 28, 2014
    3.48       2.23  
 Fourth quarter ended May 31, 2014
    3.03       1.75  
                 
Fiscal 2013:
               
 First quarter ended August 31, 2012
  $ 1.34     $ 1.00  
 Second quarter ended November 30, 2012
    1.28       0.66  
 Third quarter ended February 28, 2013
    1.11       0.75  
 Fourth quarter ended May 31, 2013
    1.50       0.72  

    At August 6, 2014, the Company had 161 holders of record of its common stock.  A substantially greater number of holders of the Company’s common stock are “street name” or beneficial holders whose shares are held by banks, brokers and other financial institutions.

    The Company has not paid cash dividends on its common stock or other securities.  The Company currently anticipates that it will retain its future earnings, if any, for use in the expansion and operation of its business and does not anticipate paying any cash dividends on its common stock in the foreseeable future.

    The Company did not repurchase any of its common stock during the fiscal year ended May 31, 2014.

EQUITY COMPENSATION PLAN INFORMATION

    The information required by this item is incorporated by reference to the information under the caption “Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters” of the Proxy Statement and Part III, Item 12 of this Annual Report on Form 10-K.

PERFORMANCE MEASUREMENT COMPARISON

    The following graph shows a comparison of total shareholder return for holders of the Company's common stock for the last five fiscal years ended May 31, 2014, compared with the NASDAQ Composite Index and the Philadelphia Semiconductor Index.  The graph assumes that $100 was invested in the Company's common stock, in the NASDAQ Composite Index and the Philadelphia Semiconductor Index on May 31, 2009, and that all dividends were reinvested.  The Company believes that while total shareholder return can be an important indicator of corporate performance, the stock prices of semiconductor equipment companies like us are subject to a number of market-related factors other than company performance, such as competitive announcements, mergers and acquisitions in the industry, the general state of the economy and the performance of other semiconductor equipment company stocks.  Stock prices and shareholder returns over the indicated period should not be considered indicative of future stock prices or shareholder returns.
 
 
 
16

 
 
 
17

 
 

    The selected consolidated financial data set forth below should be read in conjunction with “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and the consolidated financial statements and related notes included elsewhere in this Annual Report on Form 10-K.  The selected consolidated financial data in this section are not intended to replace the consolidated financial statements and are qualified in their entirety by the consolidated financial statements and related notes thereto included elsewhere in this Annual Report on Form 10-K.

    We derived the statements of operations data for the years ended May 31, 2014, 2013 and 2012 and the balance sheet data as of May 31, 2014 and 2013 from our audited consolidated financial statements and related notes, which are included elsewhere in this Annual Report on Form 10-K. We derived the statements of operations data for the years ended May 31, 2011 and 2010 and the balance sheet data as of May 31, 2012, 2011 and 2010 from our audited consolidated financial statements and related notes which are not included in this Annual Report on Form 10-K. We have not declared or distributed any cash dividends.
 
 
18

 
 
 
 
 
   
Fiscal Year Ended May 31,
 
   
2014
 
2013
 
2012
 
2011
   
2010
 
   
(In thousands, except per share data)
 
CONSOLIDATED STATEMENTS OF OPERATIONS:
                             
Net sales
                             
  Product sales
  $ 19,684     $ 16,488     $ 15,521     $ 13,737     $ 8,934  
  Cancellation charges 
    --       --       --       --       2,740  
                                         
     Total net sales
    19,684       16,488       15,521       13,737       11,674  
Cost of sales
    9,462       9,712       9,314       8,225       5,571  
Gross profit
    10,222       6,776       6,207       5,512       6,103  
                                         
Operating expenses:
                                       
  Selling, general and administrative
    6,323       6,872       6,526       5,964       6,094  
  Research and development
    3,402       3,211       4,188       4,567       4,758  
  Gain on bankruptcy claim
    --       --       --       (832 )     (3,993 )
                                         
     Total operating expenses
    9,725       10,083       10,714       9,699       6,859  
                                         
Income (loss) from operations
    497       (3,307 )     (4,507 )     (4,187 )     (756 )
                                         
Interest income
    --       --       --       3       5  
Interest expense
    (26 )     (49 )     (4 )     --       --  
Gain on sale of long-term investment
    --       --       990       --       --  
Other (expense) income, net
    (64 )     (33 )     117       762       131  
                                         
Income (loss) before income tax benefit (expense)
    407       (3,389 )     (3,404 )     (3,422 )     (620 )
                                         
Income tax benefit (expense)
    15       (30 )     15       49       139  
Net income (loss)
    422       (3,419 )     (3,389 )     (3,373 )     (481 )
     Less:  Net income (loss) attributable
         to the noncontrolling interest
    --       --       1       16       --  
                                         
Net income (loss) attributable to Aehr
     Test Systems common shareholders
  $ 422     $ (3,419 )   $ (3,390 )   $ (3,389 )   $ (481 )
Net income (loss) per share:
                                       
     Basic
  $ 0.04     $ (0.36 )   $ (0.38 )   $ (0.39 )   $ (0.06 )
     Diluted
  $ 0.04     $ (0.36 )   $ (0.38 )   $ (0.39 )   $ (0.06 )
                                         
Shares used in per share calculations:
                                       
     Basic
    10,877       9,549       9,016       8,776       8,563  
     Diluted
    11,889       9,549       9,016       8,776       8,563  
                                         
 
   
May 31,
 
   
2014
   
2013
   
2012
   
2011
   
2010
 
CONSOLIDATED BALANCE SHEETS:
                             
Cash and cash equivalents
  $ 1,809     $ 2,324     $ 2,073     $ 4,020     $ 7,766  
Working capital
    6,556       4,821       6,120       8,031       9,827  
Total assets
    12,225       10,975       11,613       12,083       14,474  
Long-term obligations, less current portion
    79       280       351       442       578  
Total shareholders' equity
    7,029       4,994       6,454       9,101       11,281  

 
19

 
 

    The following discussion and analysis of the financial condition and results of operations of the Company should be read in conjunction with our “Selected Consolidated Financial Data” and our consolidated financial statements and related notes included elsewhere in this Annual Report on Form 10-K.

OVERVIEW

    The Company was founded in 1977 to develop and manufacture burn-in and test equipment for the semiconductor industry.  Since its inception, the Company has sold more than 2,500 systems to semiconductor manufacturers, semiconductor contract assemblers and burn-in and test service companies worldwide.  The Company’s principal products currently are the Advanced Burn-in and Test System, the FOX full wafer contact parallel test and burn-in system, WaferPak contactors, the DiePak carrier and test fixtures.

    The Company’s net sales consist primarily of sales of systems, WaferPak contactors, test fixtures, die carriers, upgrades and spare parts and revenues from service contracts and engineering development charges.  The Company's selling arrangements may include contractual customer acceptance provisions, which are mostly deemed perfunctory or inconsequential, and installation of the product occurs after shipment and transfer of title.

SIGNIFICANT ITEMS IMPACTING COMPARABILITY OF FINANCIAL STATEMENTS

    Spansion, the Company’s largest customer in fiscal 2009 through 2012 and second largest customer in fiscal 2013, filed for bankruptcy in Japan in February 2009 and in the United States in March 2009.  Due to the bankruptcy filing and the impact of the weak global economic environment on demand for the Company’s products, in the third quarter of fiscal 2009, we recorded a $13.7 million provision for bad debts in selling, general and administrative expenses, a $7.2 million provision for excess and obsolete inventory and a $0.3 million charge for cancellation charges to cost of sales, a $4.9 million charge to income tax expense related to the reinstatement of the valuation allowance against the Company’s deferred tax assets, a $0.3 million charge to operating expenses related to goodwill impairment and a $0.4 million expense related to severance charges.

    The Company filed a claim in the Spansion U.S. bankruptcy action.  In the first quarter of fiscal 2010, the Company sold a portion, $11.4 million, of its Spansion U.S. bankruptcy claim to a third party for net proceeds of $3.3 million and recorded the amount as a reduction of operating expenses.  In the third quarter of fiscal 2010, the Company sold the remaining balance, $7.1 million, of its Spansion U.S. bankruptcy claim to a third party for net proceeds of $4.6 million and recorded $2.7 million as net sales related to cancellation charges, $1.3 million as deferred revenue and $0.6 million as a reduction of operating expenses.  In the fourth quarter of fiscal 2010, the Company received the remaining payment of $0.1 million due from its bankruptcy claim sale completed in the first quarter of fiscal 2010 and recognized the amount as a reduction of operating expenses.  The $1.3 million deferred revenue at the end of the third quarter of fiscal 2010 was recognized as product sales during the fourth quarter of fiscal 2010 in connection with the delivery of products.

    In the first quarter of fiscal 2011, the Company's Japanese subsidiary received approximately $0.2 million in proceeds from the Spansion Japan bankruptcy claim and recorded the amount as a reduction of operating expenses.  In the fourth quarter of fiscal 2011, the Company's Japanese subsidiary received approximately $0.7 million in proceeds from the Spansion Japan bankruptcy claim and recorded the amount as a reduction of operating expenses.

    The Company intends to take actions as necessary to maintain sufficient cash to manage through the current period of slow business activity.

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

    The Company’s discussion and analysis of its financial condition and results of operations are based upon the Company’s consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America.  The preparation of these consolidated financial statements requires the Company to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities.  On an ongoing basis, the Company evaluates its estimates, including those related to customer programs and incentives, product returns, bad debts, inventories, investments, intangible assets, income taxes, financing operations, warranty obligations, long-term service contracts, contingencies and litigation.  The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.  Actual results may differ from these estimates under different assumptions or conditions.
 
 
 
20

 
 
    The Company believes the following critical accounting policies affect its more significant judgments and estimates used in the preparation of its consolidated financial statements.

    REVENUE RECOGNITION

    The Company recognizes revenue upon the shipment of products or the performance of services when: (1) persuasive evidence of the arrangement exists; (2) services have been rendered; (3) the price is fixed or determinable; and (4) collectibility is reasonably assured.  When a sales agreement involves multiple deliverables, such as extended support provisions, training to be supplied after delivery of the systems, and test programs specific to customers’ routine applications, the multiple deliverables are evaluated to determine the unit of accounting.  Judgment is required to properly identify the accounting units of multiple element transactions and the manner in which revenue is allocated among the accounting units. Judgments made, or changes to judgments made, may significantly affect the timing or amount of revenue recognition.

    Revenue related to the multiple elements are allocated to each unit of accounting using the relative selling price hierarchy.  Consistent with accounting guidance, the selling price is based upon vendor specific objective evidence (VSOE).  If VSOE is not available, third party evidence (TPE) is used to establish the selling price.  In the absence of VSOE or TPE, estimated selling price is used.  We have adopted this guidance effective with the first quarter of fiscal 2012.  Prior to fiscal 2012, revenue for arrangements containing multiple deliverables was allocated based upon estimated fair values.  The adoption of the new revenue recognition accounting standards did not have a material impact on our consolidated financial statements.

    During the first quarter of fiscal 2013, the Company entered into an agreement with a customer to develop a next generation FOX system. The project identifies multiple milestones with values assigned to each.  The consideration earned upon achieving the milestone is required to meet the following conditions prior to recognition: (i) the value is commensurate with the vendor’s performance to meet the milestone, (ii) it relates solely to past performance, (iii) and it is reasonable relative to all of the deliverables and payment terms within the arrangement. Revenue is recognized for the milestone upon acceptance by the customer.

    Sales tax collected from customers is not included in net sales but rather recorded as a liability due to the respective taxing authorities.  Provisions for the estimated future cost of warranty and installation are recorded at the time the products are shipped.

    Royalty-based revenue related to licensing income from performance test boards and burn-in boards is recognized upon the earlier of the receipt by the Company of the licensee’s report related to its usage of the licensed intellectual property or upon payment by the licensee.

    The Company’s terms of sales with distributors are generally Free on Board, or FOB, shipping point with payment due within 60 days.  All products go through in-house testing and verification of specifications before shipment.  Apart from warranty reserves, credits issued have not been material as a percentage of net sales.  The Company’s distributors do not generally carry inventories of the Company’s products.  Instead, the distributors place orders with the Company at or about the time they receive orders from their customers.  The Company’s shipment terms to our distributors do not provide for credits or rights of return.  Because the Company’s distributors do not generally carry inventories of our products, they do not have rights to price protection or to return products.  At the time the Company ships products to the distributors, the price is fixed.   Subsequent to the issuance of the invoice, there are no discounts or special terms.  The Company does not give the buyer the right to return the product or to receive future price concessions.  The Company’s arrangements do not include vendor consideration.
 
    PRODUCT DEVELOPMENT COSTS AND CAPITALIZED SOFTWARE

    The Company capitalizes its systems software development costs incurred after a system achieves technological feasibility and before first commercial shipment.  Such costs typically represent a small portion of total research and development costs.  No system software development costs were capitalized or amortized in fiscal 2014, 2013, or 2012.

     ALLOWANCE FOR DOUBTFUL ACCOUNTS

    The Company maintains an allowance for doubtful accounts to reserve for potentially uncollectible trade receivables.  The Company also reviews its trade receivables by aging category to identify specific customers with known disputes or collection issues.  The Company exercises judgment when determining the adequacy of these reserves as the Company evaluates historical bad debt trends, general economic conditions in the United States and internationally and changes in customer financial conditions.  Uncollectible receivables are recorded as bad debt expense when all efforts to collect have been exhausted and recoveries are recognized when they are received.
 
 
21

 
 
    WARRANTY OBLIGATIONS

    The Company provides and records the estimated cost of product warranties at the time revenues are recognized on products shipped.  While the Company engages in extensive product quality programs and processes, including actively monitoring and evaluating the quality of its component suppliers, the Company’s warranty obligation is affected by product failure rates, material usage and service delivery costs incurred in correcting a product failure.  The Company’s estimate of warranty reserve is based on management’s assessment of future warranty obligations and on historical warranty obligations.  Should actual product failure rates, material usage or service delivery costs differ from the Company’s estimates, revisions to the estimated warranty liability would be required, which could affect how the Company accounts for expenses.

    INVENTORY OBSOLESCENCE

    In each of the last three fiscal years, the Company has written down its inventory for estimated obsolescence or unmarketable inventory by an amount equal to the difference between the cost of inventory and the estimated market value based upon assumptions about future demand and market conditions.  If future market conditions are less favorable than those projected by management, additional inventory write-downs may be required.

    IMPAIRMENT OF GOODWILL

    Goodwill represents the excess of the purchase price over the fair value of tangible and identifiable intangible net assets acquired in the Company’s acquisition of its Japanese subsidiary.  The Company reviews goodwill annually or whenever events or circumstances indicate that a decline in value may have occurred.  Both gross goodwill and accumulated impairment were each $274,000 at May 31, 2014, 2013 and 2012.

    INVESTMENT IMPAIRMENT

    The Company records an investment impairment charge when it believes an investment has experienced a decline in value that is other than temporary.  Future adverse changes in market conditions or poor operating results of underlying investments could result in losses or an inability to recover the carrying value of the investments that may not be reflected in an investment’s current carrying value, thereby possibly requiring an impairment charge in the future.

    INCOME TAXES

    Income taxes have been provided using the liability method whereby deferred tax assets and liabilities are determined based on differences between financial reporting and tax bases of assets and liabilities and net operating loss and tax credit carryforwards measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse or the carryforwards are utilized.  Valuation allowances are established when it is determined that it is more likely than not that such assets will not be realized.

    The Company accounts for uncertain tax positions consistent with authoritative guidance.  The guidance prescribes a “more likely than not” recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.  The Company does not expect any material change in its unrecognized tax benefits over the next twelve months.  The Company recognizes interest and penalties related to unrecognized tax benefits as a component of income taxes.

    Although the Company files U.S. federal, various state and foreign tax returns, the Company’s only major tax jurisdictions are the United States, California, Germany and Japan.  Tax years 1996 – 2013 remain subject to examination by the appropriate governmental agencies due to tax loss carryovers from those years.
 
    STOCK-BASED COMPENSATION EXPENSE

    Stock-based compensation expense consists of expenses for stock options and employee stock purchase plan, or ESPP, shares.  Stock-based compensation cost is measured at each grant date, based on the fair value of the award using the Black-Scholes option valuation model, and is recognized as expense over the employee’s requisite service period.  This model was developed for use in estimating the value of publicly traded options that have no vesting restrictions and are fully transferable.  The Company’s employee stock options have characteristics significantly different from those of publicly traded options.  All of the Company’s stock compensation is accounted for as an equity instrument.

    The fair value of each option grant and the right to purchase shares under the Company’s stock purchase plan are estimated on the date of grant using the Black-Scholes option valuation model with assumptions concerning expected term, stock price volatility, expected dividend yield, risk-free interest rate and the expected life of the award.  See Note 1
 
 
 
22

 
 
to our consolidated financial statements for additional information relating to stock-based compensation.  See Notes 10 and 11 to our consolidated financial statements for detailed information regarding the stock option plan and the ESPP.

RESULTS OF OPERATIONS

    The following table sets forth statements of operations data as a percentage of net sales for the periods indicated.

   
Year Ended May 31,
 
   
2014
   
2013
   
2012
 
                   
Net sales 
    100.0 %     100.0 %     100.0 %
Cost of sales 
    48.1       58.9       60.0  
Gross profit
    51.9       41.1       40.0  
                         
Operating expenses:
                       
  Selling, general and administrative
    32.1       41.7       42.0  
  Research and development
    17.3       19.5       27.0  
                         
     Total operating expenses
    49.4       61.2       69.0  
                         
 Net income (loss) from operations
    2.5       (20.1 )     (29.0 )
                         
Interest expense
    (0.1 )     (0.3 )     --  
Gain on sale of long-term investment
    --       --       6.4  
Other (expense) income, net
    (0.3 )     (0.2 )     0.7  
                         
 Income (loss) before income tax benefit (expense)
    2.1       (20.6 )     (21.9 )
                         
Income tax benefit (expense)
    --       (0.1 )     0.1  
                         
Net income (loss)
    2.1       (20.7 )     (21.8 )
  Less:  Net income attributable
     to the noncontrolling interest
    --       --       --  
Net income (loss) attributable to Aehr
 Test Systems common shareholders
    2.1 %     (20.7 )%     (21.8 )%


FISCAL YEAR ENDED MAY 31, 2014 COMPARED TO FISCAL YEAR ENDED MAY 31, 2013

    NET SALES.  Net sales consist primarily of sales of systems, test fixtures, die carriers, upgrades and spare parts as well as revenues from service contracts.  Net sales increased to $19.7 million for the fiscal year ended May 31, 2014 from $16.5 million for the fiscal year ended May 31, 2013, an increase of 19.4%.  The increase in net sales in fiscal 2014 was primarily due to an increase in net sales of the Company’s wafer-level products.  Net sales of the wafer-level products for fiscal 2014 were $8.3 million, and increased approximately $3.2 million from fiscal 2013.

    GROSS PROFIT.  Gross profit consists of net sales less cost of sales.  Cost of sales consists primarily of the cost of materials, assembly and test costs, and overhead from operations.  Gross profit increased to $10.2 million for the fiscal year ended May 31, 2014 from $6.8 million for the fiscal year ended May 31, 2013, an increase of 50.9% primarily due to an increase in net sales.  Gross profit margin for the fiscal year ended May 31, 2014 was 51.9%, compared with 41.1% for the fiscal year ended May 31, 2013. The increase in gross profit margin was primarily due to decreased direct material costs resulting from the sales of certain systems which included previously written-down material.

    SELLING, GENERAL AND ADMINISTRATIVE.  Selling, general and administrative, or SG&A, expenses consist primarily of salaries and related costs of employees, customer support costs, commission expenses to independent sales representatives, product promotion, other professional services and bad debt expenses.  SG&A expenses were $6.3 million for the fiscal year ended May 31, 2014, compared with $6.9 million for the fiscal year ended May 31, 2013, a decrease of 8.0%.  The decrease in SG&A expenses was primarily due to decreases of $0.3 million in sales commissions to outside sales representatives and $0.2 million in pre-sales support expenses.
 
 
 
23

 
 
    RESEARCH AND DEVELOPMENT.  Research and development, or R&D, expenses consist primarily of salaries and related costs of employees engaged in ongoing research, design and development activities, costs of engineering materials and supplies and professional consulting expenses.  R&D expenses increased to $3.4 million for the fiscal year ended May 31, 2014 from $3.2 million for the fiscal year ended May 31, 2013, an increase of 5.9%.  The increase in R&D expenses was primarily due to increases of $0.3 million of project expenses and $0.2 million of outside services.  These were partially offset by an increase of $0.4 million of R&D expenditures, related to non-recurring engineering milestones, transferred into cost of goods sold and prepaid expenses.

    INTEREST EXPENSE.  Interest expense decreased to $26,000 for the fiscal year ended May 31, 2014 from $49,000 for the fiscal year ended May 31, 2013 as a result of lower average borrowings on the line of credit.

    OTHER (EXPENSE) INCOME, NET.  Other expense, net increased to $64,000 for the fiscal year ended May 31, 2014 from $33,000 for the fiscal year ended May 31, 2013.  The change in other expense was due to foreign exchange losses resulting from the fluctuation in the value of the dollar compared to foreign currencies.
 
    INCOME TAX BENEFIT (EXPENSE).  Income tax expense was $30,000 for the fiscal year ended May 31, 2013, compared with income tax benefit of $15,000 for the fiscal year ended May 31, 2012.  The income tax benefits for the fiscal year ended May 31, 2012 were due to the reversal of tax liabilities previously established, which were no longer required.

FISCAL YEAR ENDED MAY 31, 2013 COMPARED TO FISCAL YEAR ENDED MAY 31, 2012

    NET SALES.  Net sales consist primarily of sales of systems, test fixtures, die carriers, upgrades and spare parts as well as revenues from service contracts.  Net sales increased to $16.5 million for the fiscal year ended May 31, 2013 from $15.5 million for the fiscal year ended May 31, 2012, an increase of 6.2%.  The increase in net sales in fiscal 2013 was primarily due to an increase in net sales of the Company’s TDBI products, partially offset by a decrease of the Company’s wafer-level products.  Net sales of the Company’s TDBI products for fiscal 2013 were $11.2 million, and increased approximately $4.5 million from fiscal 2012.  Net sales of the wafer-level products for fiscal 2013 were $5.1 million, and decreased approximately $3.1 million from fiscal 2012.

    GROSS PROFIT.  Gross profit consists of net sales less cost of sales.  Cost of sales consists primarily of the cost of materials, assembly and test costs, and overhead from operations.  Gross profit increased to $6.8 million for the fiscal year ended May 31, 2013 from $6.2 million for the fiscal year ended May 31, 2012, an increase of 9.2% primarily due to an increase in net sales.  Gross profit margin for the fiscal year ended May 31, 2013 was 41.1%, compared with 40.0% for the fiscal year ended May 31, 2012.

    SELLING, GENERAL AND ADMINISTRATIVE.  Selling, general and administrative, or SG&A, expenses consist primarily of salaries and related costs of employees, customer support costs, commission expenses to independent sales representatives, product promotion, other professional services and bad debt expenses.  SG&A expenses were $6.9 million for the fiscal year ended May 31, 2013, compared with $6.5 million for the fiscal year ended May 31, 2012, an increase of 5.3%.  The increase in SG&A expenses was primarily due to an increase in sales expenses of $0.3 million related primarily to pre-sales support activities, and an increase in commissions of $0.3 million.  This was offset by a reduction in employment related expenses of $0.1 million.

    RESEARCH AND DEVELOPMENT.  Research and development, or R&D, expenses consist primarily of salaries and related costs of employees engaged in ongoing research, design and development activities, costs of engineering materials and supplies and professional consulting expenses.  R&D expenses decreased to $3.2 million for the fiscal year ended May 31, 2013 from $4.2 million for the fiscal year ended May 31, 2012, a decrease of 23.3%.  The decrease in R&D expenses was primarily due to decreases of $0.3 million of employment related expenses and $0.3 million of project expenses and outside services.  Certain R&D expenditures related to non-recurring engineering milestones were transferred into cost of goods sold.

    INTEREST EXPENSE.  Interest expense increased to $49,000 for the fiscal year ended May 31, 2013 from $4,000 for the fiscal year ended May 31, 2012 as a result of higher average borrowings on the line of credit.

    GAIN ON SALE OF LONG-TERM INVESTMENT.  During the first quarter of fiscal 2012, the Company sold its long-term investment in ESA Electronics PTE Ltd, or ESA, resulting in a gain of approximately $1.0 million.

    OTHER (EXPENSE) INCOME, NET.  Other expense, net for the fiscal year ended May 31, 2013 was $33,000, compared to other income, net of $117,000 for the fiscal year ended May 31, 2012.  The change in other (expense) income was due to the fluctuation in the value of the dollar compared to foreign currencies.

 
24

 
 
    INCOME TAX BENEFIT (EXPENSE).  Income tax expense was $30,000 for the fiscal year ended May 31, 2013, compared with income tax benefit of $15,000 for the fiscal year ended May 31, 2012.  The income tax benefits for the fiscal year ended May 31, 2012 were due to the reversal of tax liabilities previously established, which were no longer required.

LIQUIDITY AND CAPITAL RESOURCES

    We consider cash and cash equivalents as liquid and available for use.  As of May 31, 2014, the Company had $1.8 million in cash and cash equivalents, compared to $2.3 million as of May 31, 2013.

    Net cash used in operating activities was $0.6 million and $0.3 million for the fiscal years ended May 31, 2014 and 2013, respectively.  For the fiscal year ended May 31, 2014, net cash used in operating activities was primarily the result of net income of $0.4 million, as adjusted to exclude the effect of non-cash charges including stock-based compensation expense of $0.8 million, a decrease in customer deposits and deferred revenue of $1.0 million and an increase in inventories of $0.7 million.  The decrease in customer deposits and deferred revenue was primarily due to the shipments against customer orders with down payments.  The increase in inventories was primarily due to inventory purchases to support future shipments.  For the fiscal year ended May 31, 2013, net cash used in operating activities was primarily the result of the net loss of $3.4 million, as adjusted to exclude the effect of non-cash charges including stock-based compensation expense of $0.6 million and depreciation and amortization of $0.3 million, an increase in customer deposits and deferred revenue of $1.5 million and a decrease in inventories of $0.7 million.  The increase in customer deposits and deferred revenue was primarily due to 30% down payments from certain customers.  The decrease in inventories was primarily due to $0.4 million in inventory usage as well as one-time charges of $0.3 million related to write-downs of older product inventory.

    Net cash used in investing activities was $0.3 million for the fiscal year ended May 31, 2014 as compared to net cash used in investing activities of $0.1 million for the fiscal year ended May 31, 2013.  Net cash used in investing activities during the fiscal years ended May 31, 2014 and 2013 was primarily due to the purchase of property and equipment.
 
    Financing activities provided cash of $0.4 million for the fiscal year ended May 31, 2014 as compared to $1.1 million for the fiscal year ended May 31, 2013.  Net cash provided by financing activities during the fiscal year ended May 31, 2014 was primarily due to $715,000 in proceeds from issuance of common stock and exercise of stock options, partially offset by net repayments under the line of credit of $324,000.  Refer to Note 9 of Notes to Consolidated Financial Statements, “LINE OF CREDIT”, for further discussion of the credit facility agreement.  Net cash provided by financing activities during the fiscal year ended May 31, 2013 was primarily due to $1.1 million in common stock sold in the Company’s private placement.

    As of May 31, 2014, the Company had working capital of $6.6 million.  Working capital consists of cash and cash equivalents, accounts receivable, inventories and prepaid expenses and other current assets, less current liabilities.

    As of May 31, 2013, the Company had $2.3 million in cash and cash equivalents, compared to $2.1 million as of May 31, 2012.

    As of May 31, 2013, the Company had working capital of $4.8 million.

    For the fiscal year ended May 31, 2012, net cash used in operating activities was primarily the result of the net loss of $3.4 million, as adjusted to exclude the effect of non-cash charges including stock-based compensation expense of $0.7 million and depreciation and amortization of $0.5 million, and a gain of approximately $1.0 million on the sale of the Company’s long-term investment in ESA Electronics PTE Ltd., and increases in accounts receivable of $1.3 million and inventories of $1.1 million, partially offset by an increase in accounts payable of $0.6 million.  The increase in accounts receivable was primarily due to an increase in revenues in fiscal year 2012 compared to fiscal year 2011.  The increase in inventories was to support future shipments for customer orders.  The increase in accounts payable was due primarily to inventory purchases to support future shipments.

    Net cash provided by investing activities for the fiscal year ended May 31, 2012 was due primarily to the $1.4 million in proceeds received from the sale of the Company’s long-term investment in ESA Electronics PTE Ltd.

    Net cash provided by financing activities during the fiscal year ended May 31, 2012 was primarily due to a $1.4 million draw on our line of credit.  Refer to Note 9 of Notes to Consolidated Financial Statements, “LINE OF CREDIT”, for further discussion of the credit facility agreement.

    The Company leases its manufacturing and office space under operating leases.  The Company entered into a non-cancelable operating lease agreement for its United States manufacturing and office facilities, which commenced in April
 
 
 
25

 
 
2008 and expires in June 2015.  Under the lease agreement, the Company is responsible for payments of utilities, taxes and insurance.

    From time to time, the Company evaluates potential acquisitions of businesses, products or technologies that complement the Company’s business.  If consummated, any such transactions may use a portion of the Company’s working capital or require the issuance of equity.  The Company has no present understandings, commitments or agreements with respect to any material acquisitions.

    The Company anticipates that the existing cash balance together with cash flows from operations, as well as funds available through the working capital credit facility will be adequate to meet its working capital and capital equipment requirements through fiscal 2015.   Refer to Note 9 of Notes to Consolidated Financial Statements, “LINE OF CREDIT”, for further discussion of the credit facility agreement.  After fiscal 2015, depending on its rate of growth and profitability, the Company may require additional equity or debt financing to meet its working capital requirements or capital equipment needs.  There can be no assurance that additional financing will be available when required, or if available, that such financing can be obtained on terms satisfactory to the Company.
    
OFF-BALANCE SHEET FINANCING

    The Company has not entered into any off-balance sheet financing arrangements and has not established any special purpose entities.

OVERVIEW OF CONTRACTUAL OBLIGATIONS

    The following table provides a summary of such arrangements, or contractual obligations.

   
Payments Due by Period (in thousands)
   
         
Less than
     1-3      3-5      5  
   
Total
   
1 year
   
years
   
years
   
years
 
Operating Leases
  $ 696     $ 623     $ 73     $ --     $ --  
Line of Credit
    777       777       --       --       --  
Purchases(1)
    1,491       1,491       --       --       --  
Total
  $ 2,964     $ 2,891     $ 73     $ --     $ --  
 
(1)  Shown above are the Company’s binding purchase obligations. The large majority of the Company’s purchase orders are cancelable by either party, which if canceled may result in a negotiation with the vendor to determine if there shall be any restocking or cancellation fees payable to the vendor.

    In the normal course of business to facilitate sales of its products, the Company indemnifies other parties, including customers, with respect to certain matters.  The Company has agreed to hold the other party harmless against losses arising from a breach of representations or covenants, or from intellectual property infringement or other claims.  These agreements may limit the time period within which an indemnification claim can be made and the amount of the claim.  In addition, the Company has entered into indemnification agreements with its officers and directors, and the Company’s bylaws contain similar indemnification obligations to the Company’s agents.

It is not possible to determine the maximum potential amount under these indemnification agreements due to the limited history of prior indemnification claims and the unique facts and circumstances involved in each particular agreement.  To date, payments made by the Company under these agreements have not had a material impact on the Company’s operating results, financial position or cash flows.

RECENT ACCOUNTING PRONOUNCEMENTS:

    In May 2014, the Financial Accounting Standards Board ("FASB")  issued Accounting Standards Update ("ASU")  No. 2014-09, Revenue from contracts with customers, a new standard on revenue recognition.  The new standard will supersede existing revenue recognition guidance and apply to all entities that enter into contracts to provide goods or services to customers.  The guidance also addresses the measurement and recognition of gains and losses on the sale of certain non-financial assets, such as real estate, and property and equipment.  The new standard will become effective for us beginning with the first quarter of 2017 and can be adopted either retrospectively to each reporting period presented or as a cumulative effect adjustment as of the date of adoption.  We are currently evaluating the impact of adopting this new guidance on our consolidated financial statements.
    
 
26

 
 

    The Company had no holdings of derivative financial or commodity instruments at May 31, 2014.

    The Company is exposed to financial market risks, including changes in interest rates and foreign currency exchange rates.  The Company only invests its short-term excess cash in government-backed securities with maturities of 18 months or less.  The Company does not use any financial instruments for speculative or trading purposes.  Fluctuations in interest rates would not have a material effect on the Company’s financial position, results of operations or cash flows.

    A majority of the Company’s revenue and capital spending is transacted in U.S. Dollars.  The Company, however, enters into transactions in other currencies, primarily Euros and Japanese Yen.  Since the price is determined at the time a purchase order is accepted, the Company is exposed to the risks of fluctuations in the foreign currency-U.S. Dollar exchange rates during the lengthy period from purchase order to ultimate payment.  This exchange rate risk is partially offset to the extent that the Company’s subsidiaries incur expenses payable in their local currency.  To date, the Company has not invested in instruments designed to hedge currency risks.  In addition, the Company’s subsidiaries typically carry debt or other obligations due to the Company that may be denominated in either their local currency or U.S. Dollars.  Since the Company’s subsidiaries’ financial statements are based in their local currency and the Company’s condensed consolidated financial statements are based in U.S. Dollars, the Company’s subsidiaries and the Company recognize foreign exchange gains or losses in any period in which the value of the local currency rises or falls in relation to the U.S. Dollar.  A 10% decrease in the value of the subsidiaries’ local currency as compared with the U.S. Dollar would not be expected to result in a significant change to the Company’s net income or loss. There have been no material changes in our risk exposure since the end of the last fiscal year, nor are any material changes to our risk exposure anticipated.
 
 
 
27

 
 
 
INDEX
 
Consolidated Financial Statements of Aehr Test Systems
     
       
    29  
         
    30  
         
    31  
 
       
    32  
         
    33  
         
    34  
         
    35  
         
 
Financial statement schedules not listed above are either omitted because they are not applicable or the required information is shown in the Consolidated Financial Statements or in the Notes thereto.
 
 
28

 
 
 REPORT OF
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM



To the Board of Directors and Shareholders of
Aehr Test Systems
 
    We have audited the accompanying consolidated balance sheets of Aehr Test Systems and its subsidiaries (the “Company”) as of May 31, 2014 and 2013, and the related consolidated statements of operations, comprehensive income (loss), shareholders’ equity and cash flows for each of the years in the three-year period ended May 31, 2014. These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits.
 
    We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. The Company is not required to have, nor have we been engaged to perform, an audit of the Company’s internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.
 
    In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of Aehr Test Systems and its subsidiaries as of May 31, 2014 and 2013, and the results of their operations and their cash flows for each of the years in the three-year period ended May 31, 2014, in conformity with accounting principles generally accepted in the United States of America.


/s/ Burr Pilger Mayer, Inc.


E. Palo Alto, California
August 28, 2014
 
 
29

 
 
 

   
May 31,
 
   
2014
   
2013
 
ASSETS
           
             
Current assets:
           
  Cash and cash equivalents
  $ 1,809     $ 2,324  
  Accounts receivable, net
    3,390       2,632  
  Inventories
    6,148       5,369  
  Prepaid expenses and other
    326       276  
                 
     Total current assets
    11,673       10,601  
                 
Property and equipment, net
    474       301  
Other assets  
    78       73  
                 
     Total assets
  $ 12,225     $ 10,975  
                 
LIABILITIES AND SHAREHOLDERS' EQUITY
               
                 
Current liabilities:
               
  Line of credit
  $ 777     $ 1,101  
  Accounts payable  
    1,892       1,188  
  Accrued expenses
    1,390       1,440  
  Customer deposits and deferred revenue, short-term
    1,058       1,972  
                 
     Total current liabilities
    5,117       5,701  
                 
Income tax payable
    71       109  
Deferred rent, net of current portion
    8       103  
Deferred revenue, long-term
    --       68  
     Total liabilities
    5,196       5,981  
                 
Commitments and contingencies (Note 15)
               
                 
Aehr Test Systems shareholders' equity:
               
  Preferred stock, $0.01 par value:
               
    Authorized: 10,000 shares;
               
    Issued and outstanding: none
    --       --  
  Common stock, $0.01 par value:
               
    Authorized: 75,000 shares;
               
    Issued and outstanding: 11,203 shares and 10,599 shares at May 31, 2014 and 2013, respectively
    112       106  
  Additional paid-in capital
    52,142       50,580  
  Accumulated other comprehensive income
    2,488       2,442  
  Accumulated deficit
    (47,692 )     (48,114 )
    Total Aehr Test Systems shareholders' equity
    7,050       5,014  
Noncontrolling interest.
    (21 )     (20 )
     Total shareholders' equity
    7,029       4,994  
                 
     Total liabilities and shareholders' equity
  $ 12,225     $ 10,975  

 
The accompanying notes are an integral part of these consolidated financial statements.


 
30

 
 

   
Year Ended May 31,
 
   
2014
   
2013
   
2012
 
                   
Net sales
  $ 19,684     $ 16,488     $ 15,521  
Cost of sales
    9,462       9,712       9,314  
Gross profit
    10,222       6,776       6,207  
                         
Operating expenses:
                       
  Selling, general and administrative
    6,323       6,872       6,526  
  Research and development 
    3,402       3,211       4,188  
                         
    Total operating expenses
    9,725       10,083       10,714  
                         
Income (loss) from operations
    497       (3,307 )     (4,507 )
                         
Interest expense
    (26 )     (49 )     (4 )
Gain on sale of long-term investment
    --       --       990  
Other (expense) income, net
    (64 )     (33 )     117  
                         
Income (loss) before income tax benefit (expense)
    407       (3,389 )     (3,404 )
                         
Income tax benefit (expense)
    15       (30 )     15  
Net income (loss)
    422       (3,419 )     (3,389 )
   Less:  Net income attributable
    to the noncontrolling interest
    --       --       1  
                         
Net income (loss) attributable to Aehr
   Test Systems common shareholders
  $ 422     $ (3,419 )   $ (3,390 )
                         
                         
                         
Net income (loss) per share – basic and diluted
  $ 0.04     $ (0.36 )   $ (0.38 )
Shares used in per share calculation – basic
    10,877       9,549       9,016  
Shares used in per share calculation – diluted
    11,889       9,549       9,016  



The accompanying notes are an integral part of these consolidated financial statements.
 
 
31

 
 


   
Year Ended May 31,
 
   
2014
   
2013
   
2012
 
                   
                   
Net income (loss)
  $ 422     $ (3,419 )   $ (3,389 )
                         
Other comprehensive income (loss), net of tax:
    Foreign currency translation income (loss)
    45       (14 )     (135 )
                         
Total comprehensive income (loss)
    467       (3,433 )     (3,524 )
 
Less:  Comprehensive (loss) income attributable to
       noncontrolling interest
    (1 )     2       1  
                         
Comprehensive income (loss), attributable to
  Aehr Test Systems
  $ 468     $ (3,435 )   $ (3,525 )


The accompanying notes are an integral part of these consolidated financial statements.
 
 
32

 
 
 
   
Common Stock
     
Additional
Paid-in
     
Accumulated
Other
Comprehensive
     
Accumulated
   
Total Aehr
Test
Systems
 Shareholders’
     
Noncontrolling
     
 
 Total
Shareholders'
 
   
Shares
   
Amount
   
Capital
   
Income
   
Deficit
   
Equity
   
Interest
   
Equity
 
Balances, May 31, 2011
    8,932     $ 89     $ 47,747     $ 2,593     $ (41,305 )   $ 9,124     $ (23 )   $ 9,101  
                                                                 
  Issuance of common stock
                                                               
    under employee plans
    203       2       166       --       --       168       --       168  
  Stock-based compensation
--
      --       709       --       --       709       --       709  
  Net (loss) income
    --       --       --       --       (3,390 )     (3,390 )     1       (3,389 )
  Foreign currency
                                                               
    translation adjustment
    --       --       --       (135 )     --       (135 )     --       (135 )
                                                                 
Balances, May 31, 2012
    9,135       91       48,622       2,458       (44,695 )     6,476       (22 )     6,454  
                                                                 
  Issuance of common stock
                                                               
    under private placement
    1,158       12       1,126       --       --       1,138       --       1,138  
  Issuance of common stock
                                                               
    under employee plans
    306       3       231       --       --       234       --       234  
  Stock-based compensation
--
      --       601       --       --       601       --       601  
  Net loss
    --       --       --       --       (3,419 )     (3,419 )     --       (3,419 )
  Foreign currency
                                                               
    translation adjustment
    --       --       --       (16 )     --       (16 )     2       (14 )
                                                                 
Balances, May 31, 2013
    10,599       106       50,580       2,442       (48,114 )     5,014       (20 )     4,994  
                                                                 
  Issuance of common stock
                                                               
    under employee plans
    604       6       709       --       --       715       --       715  
  Stock-based compensation.
--
      --       853       --       --       853       --       853  
  Net income
    --       --       --       --       422       422       --       422  
  Foreign currency
                                                               
    translation adjustment
    --       --       --       46       --       46       (1 )     45  
                                                                 
Balances, May 31, 2014
    11,203     $ 112     $ 52,142     $ 2,488     $ (47,692 )   $ 7,050     $ (21 )   $ 7,029  

The accompanying notes are an integral part of these consolidated financial statements.
 
 
33

 
 
 
 
<
   
Year Ended May 31,
 
   
2014
   
2013
   
2012
 
Cash flows from operating activities:
                 
  Net income (loss)
  $ 422     $ (3,419 )   $ (3,389 )
  Adjustments to reconcile net income (loss) to net cash
                       
    used in operating activities:
                       
    Stock-based compensation expense
    829       601       709  
    Provision for doubtful accounts
    15       --       16  
    (Gain) loss on disposal of asset
    (41 )     --       1  
    Gain on sale of long-term investment
    --       --       (990 )
    Depreciation and amortization
    141       322       491  
    Changes in operating assets and liabilities:
                       
      Accounts receivable
    (720 )     (206 )     (1,285 )
      Inventories
    (740 )     702       (1,114 )
      Prepaid expenses and other
    (51 )     (7 )     (42 )
      Accounts payable
    707       243       570  
      Customer deposits and deferred revenue
    (984 )     1,477       331  
      Accrued expenses
    (25 )     58       (36 )
      Income tax payable
    (65 )     (5 )     (78 )
      Deferred rent
    (95 )     (76 )     (59 )
        Net cash used in
                       
          operating activities
    (607 )     (310 )     (4,875 )
                         
Cash flows from investing activities:
                       
    Proceeds from sales of investments
    --       --       1,375  
    Proceeds from sales of property and equipment
    50       --       --  
    Purchases of property and equipment
    (339 )     (127 )     (45 )
                         
        Net cash (used in) provided by
                       
          investing activities.
    (289 )     (127 )     1,330  
                         
Cash flows from financing activities:
                       
    Line of credit (repayments) borrowings, net
    (324 )     (307 )     1,408  
    Proceeds from issuance of common stock
                       
       under private placement
    --       1,138       --  
    Proceeds from issuance of common stock
                       
       under employee plans
    715       234       168  
                         
        Net cash provided by
                       
          financing activities
    391       1,065       1,576  
                         
                         
Effect of exchange rates on cash and
                       
    cash equivalents
    (10 )     (377 )     22  
                         
        Net (decrease) increase in cash and
                       
          cash equivalents
    (515 )     251       (1,947 )
                         
Cash and cash equivalents, beginning of year
    2,324       2,073